https://curecurrent.com/trials/external-beam-therapy-with-theranostic-radioligand-therapy-for-oligometastatic-prostate-cancer-prostact-target-57001https://curecurrent.com/trials/18f-dcfpyl-pet-mri-in-regional-nodal-distant-metastases-detection-in-intermediate-hr-prostate-cancer-57002https://curecurrent.com/trials/a-multicenter-study-evaluating-the-diagnostic-value-of-68ga-my6349-pet-ct-for-prostate-cancer-57003https://curecurrent.com/trials/abiraterone-acetate-niclosamide-and-prednisone-in-treating-patients-with-hormone-resistant-prostate-cancer-57004https://curecurrent.com/trials/psma-pet-ct-registry-57005https://curecurrent.com/trials/study-of-hrs-2189-combined-hrs-5041-in-prostate-cancer-57006https://curecurrent.com/trials/the-remote-study-investigating-the-effects-or-online-exercise-on-quality-of-life-in-men-with-prostate-cancer-57007https://curecurrent.com/trials/a-phase-i-iia-study-of-uv1-vaccine-in-patients-with-prostate-cancer-57008https://curecurrent.com/trials/a-phase-i-trial-of-61cu-nodaga-psma-for-patients-with-prostate-cancer-57009https://curecurrent.com/trials/psma-based-18f-dcfpyl-pet-ct-and-pet-mri-pilot-studies-in-prostate-cancer-57010https://curecurrent.com/trials/remimazolam-versus-propofol-for-general-anesthesia-induction-in-patients-on-renin-angiotensin-system-blockers-undergoing-57011https://curecurrent.com/trials/retzius-sparing-robot-assisted-radical-prostatectomy-with-sandwich-technique-of-total-urethral-reconstruction-versus-sta-57012https://curecurrent.com/trials/a-phase-1-2-clinical-trial-to-evaluate-the-safety-tolerability-dosimetry-and-anti-tumor-activity-of-ga-68-ngul-lu-177-dg-57013https://curecurrent.com/trials/177lu-lnc1011-in-patients-with-metastatic-castration-resistant-prostate-cancer-57014https://curecurrent.com/trials/a-clinical-study-of-onct-534-in-subjects-with-metastatic-castration-resistant-prostate-cancer-57015https://curecurrent.com/trials/trial-of-rad-223-activity-in-asymptomatic-patients-with-mcrpc-while-on-abiraterone-or-enzalutamide-besides-ar-v7-status-57016https://curecurrent.com/trials/investigation-of-the-diagnostic-role-of-mirnas-in-pca-and-bph-57017https://curecurrent.com/trials/a-study-to-determine-safety-and-tolerability-of-enzalutamide-mdv3100-in-combination-with-abiraterone-acetate-in-bone-met-57018https://curecurrent.com/trials/multicenter-trial-of-abiraterone-acetate-with-or-without-cabazitaxel-in-treatment-of-metastatic-castration-resistant-pro-57019https://curecurrent.com/trials/long-term-tarp-vaccination-using-a-multi-epitope-tarp-peptide-autologous-dendritic-cell-vaccination-in-previously-vaccin-57020https://curecurrent.com/trials/investigator-initiated-trial-to-further-evaluate-the-safety-and-efficacy-of-trans-perineal-focal-laser-ablation-of-local-57021https://curecurrent.com/trials/assessing-dna-changes-in-high-risk-prostate-cancer-to-determine-prognosis-57022https://curecurrent.com/trials/head-to-head-comparison-of-68ga-psma-11-and-18f-psma-1007-57023https://curecurrent.com/trials/the-predictive-value-of-tmprss2-erg-fusion-in-high-risk-prostate-cancer-patient-57024https://curecurrent.com/trials/the-bispecific-psmaxcd3-antibody-cc-1-in-patients-with-castration-resistant-prostate-carcinoma-57025https://curecurrent.com/trials/psma-expression-and-psma-pet-imaging-in-soft-tissue-sarcomas-and-urothelial-cell-carcinomas-57026https://curecurrent.com/trials/comparative-study-of-use-of-alpha-blockers-to-treat-symptoms-in-prostate-cancer-patients-undergoing-radiation-therapy-57027https://curecurrent.com/trials/peace-v-salvage-treatment-of-oligorecurrent-nodal-prostate-cancer-metastases-57028https://curecurrent.com/trials/study-on-enzalutamide-and-flutamide-in-patients-with-castration-resistant-prostate-cancer-57029https://curecurrent.com/trials/a-study-to-evaluate-the-potential-increased-risk-of-seizures-among-metastatic-castration-resistant-prostate-cancer-mcrpc-57030https://curecurrent.com/trials/a-study-of-enzalutamide-versus-bicalutamide-in-castrate-men-with-metastatic-prostate-cancer-57031https://curecurrent.com/trials/kidney-function-and-risk-factors-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-undergoing-177lu-57032https://curecurrent.com/trials/a-study-to-evaluate-enzalutamide-after-abiraterone-in-metastatic-castration-resistant-prostate-cancer-57033https://curecurrent.com/trials/a-randomized-study-of-enzalutamide-in-patients-with-localized-prostate-cancer-undergoing-active-surveillance-57034https://curecurrent.com/trials/a-study-to-assess-the-safety-of-continued-administration-of-mdv3100-in-subjects-with-prostate-cancer-who-showed-benefit-57035https://curecurrent.com/trials/the-efficacy-and-safety-of-prostatectomy-for-castration-naive-oligometastatic-prostate-cancer-57036https://curecurrent.com/trials/mr-guided-prostate-stereotactic-body-radiotherapy-in-seven-days-57037https://curecurrent.com/trials/comparison-capsule-sparing-cystectomy-and-radical-cystoprostatectomy-in-men-with-bladder-cancer-57038https://curecurrent.com/trials/management-of-castration-resistant-prostate-cancer-with-oligometastases-57039https://curecurrent.com/trials/the-predictive-value-of-coexisting-tmprss2-erg-gene-fusion-and-pten-deletion-in-prostate-cancer-patients-with-biochemica-57040https://curecurrent.com/trials/a-intervention-for-reducing-sedentary-behaviour-among-prostate-cancer-survivors-57041https://curecurrent.com/trials/hypofractionated-dose-escalation-radiotherapy-for-high-risk-adenocarcinoma-of-the-prostate-57042https://curecurrent.com/trials/genetics-of-prostate-cancer-in-young-patients-57043https://curecurrent.com/trials/fluciclovine-f18-pet-ct-imaging-in-assessing-hormone-naive-men-with-prostate-cancer-that-has-spread-to-the-bone-57044https://curecurrent.com/trials/prognostic-study-of-prostate-cancer-via-dynamic-change-of-psa-in-peritoneal-drainage-fluid-after-radical-prostatectomy-57045https://curecurrent.com/trials/apaca-apheresis-acoustophoresis-and-molecular-characterization-of-prostate-cancer-57046https://curecurrent.com/trials/focal-salvage-hdr-brachytherapy-for-the-treatment-of-prostate-cancer-57047https://curecurrent.com/trials/pilot-study-of-whole-gland-salvage-hdr-prostate-brachytherapy-for-locally-recurrent-prostate-cancer-57048https://curecurrent.com/trials/intense-exercise-for-survival-among-men-with-metastatic-prostate-cancer-interval-gap4-57049https://curecurrent.com/trials/prognostic-study-of-via-dynamic-change-of-dt-dna-in-drainage-fluid-after-radical-prostatectomy-57050https://curecurrent.com/trials/prognostic-study-of-via-dynamic-change-of-pca3-mrna-in-drainage-fluid-after-radical-prostatectomy-57051https://curecurrent.com/trials/18f-fluciclovine-pet-ct-impact-on-predicting-clinical-outcome-of-177lu-psma-617-therapy-in-patients-with-prostate-cancer-57052https://curecurrent.com/trials/a-study-of-eligard-in-hormone-dependent-prostate-cancer-patients-57053https://curecurrent.com/trials/phase-ii-randomised-controlled-trial-of-patient-specific-adaptive-vs-continuous-abiraterone-or-enzalutamide-in-mcrpc-57054https://curecurrent.com/trials/micro-rnas-to-predict-response-to-androgen-deprivation-therapy-57055https://curecurrent.com/trials/mri-guided-transurethral-hifu-for-various-prostate-diseases-57056https://curecurrent.com/trials/the-performance-of-mri-prostate-in-men-with-different-prostate-health-index-phi-values-57057https://curecurrent.com/trials/mri-prostate-for-chinese-men-being-screened-for-prostate-cancer-57058https://curecurrent.com/trials/biomarker-driven-intermittent-docetaxel-in-metastatic-castration-resistant-prostate-cancer-57059https://curecurrent.com/trials/a-study-of-mdv3100-to-evaluate-safety-tolerability-pharmacokinetics-and-efficacy-of-in-prostate-cancer-patients-57060https://curecurrent.com/trials/a-registry-based-study-evaluating-overall-survival-and-treatment-length-in-mcrpc-patients-treated-with-enzalutamide-in-s-57061https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-in-participants-with-metastatic-castration-resistant-prostate-cancer-mcrpc-mk-3475-199-ke-57062https://curecurrent.com/trials/long-term-specified-drug-use-results-survey-for-xtandi-capsule-57063https://curecurrent.com/trials/survey-based-discrete-choice-experiment-study-in-prostate-cancer-decider-study-57064https://curecurrent.com/trials/non-interventional-study-to-establish-consensus-on-management-of-metastatic-hormone-sensitive-prostate-cancer-patients-57065https://curecurrent.com/trials/a-study-to-monitor-the-safety-of-enzalutamide-in-patients-with-progressive-castration-resistant-prostate-cancer-previous-57066https://curecurrent.com/trials/comparison-of-mri-ai-ctb-versus-routine-ctb-in-prostate-cancer-diagnosis-a-prospective-randomized-controlled-trial-57067https://curecurrent.com/trials/observational-cohort-study-of-patients-with-castration-resistant-prostate-cancer-crpc-57068https://curecurrent.com/trials/pembrolizumab-in-metastatic-castration-resistant-prostate-cancer-mcrpc-with-or-without-dna-damage-repair-defects-57069https://curecurrent.com/trials/pilot-cohort-study-of-rb-82-myocardial-pet-imaging-to-evaluate-coronary-microvascular-dysfunction-in-men-with-prostate-c-57070https://curecurrent.com/trials/multi-target-tracking-in-prostate-radiotherapy-using-mlc-and-kim-57071https://curecurrent.com/trials/cart-psma-cells-for-advanced-prostate-cancer-57072https://curecurrent.com/trials/combined-psma-pet-mri-for-detection-of-lymph-node-metastases-in-high-risk-prostate-cancer-patients-57073https://curecurrent.com/trials/psma-pet-and-mri-for-detection-of-recurrent-prostate-cancer-after-radical-treatment-57074https://curecurrent.com/trials/two-fraction-versus-five-fraction-stereotactic-radiotherapy-for-localized-prostate-cancer-57075https://curecurrent.com/trials/enzalutamide-dutasteride-finasteride-as-1st-line-treatment-for-patients-65-years-old-with-prostate-cancer-57076https://curecurrent.com/trials/focal-mr-guided-focused-ultrasound-treatment-of-localized-intermediate-risk-prostate-lesions-57077https://curecurrent.com/trials/study-on-human-bioequivalence-of-triprerelin-acetate-for-injection-57078https://curecurrent.com/trials/stereotactic-radiotherapy-of-prostate-cancer-with-reduction-of-safety-margins-57079https://curecurrent.com/trials/a-phase-iii-study-for-patients-with-metastatic-hormone-na-ve-prostate-cancer-57080https://curecurrent.com/trials/dosimetry-safety-and-potential-benefit-of-177lu-psma-617-prior-to-prostatectomy-57081https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-antitumor-activity-of-a-thorium-227-labeled-antibody-chel-57082https://curecurrent.com/trials/onvansertib-in-combination-with-abiraterone-and-prednisone-in-adult-patients-with-metastatic-castration-resistant-prosta-57083https://curecurrent.com/trials/pathological-positivity-rate-in-prostate-cancer-patients-with-pi-rads-4-and-first-negative-biopsy-57084https://curecurrent.com/trials/68ga-p3-pet-ct-imaging-in-prostate-57085https://curecurrent.com/trials/psma-pet-ct-for-assessment-of-recurrent-prostate-cancer-57086https://curecurrent.com/trials/art-pro-clinical-trial-evaluating-biparametric-mri-and-advanced-quantitative-diffusion-mri-for-detection-of-prostate-can-57087https://curecurrent.com/trials/effectiveness-of-open-and-robotic-prostatectomy-57088https://curecurrent.com/trials/customized-tulsa-pro-ablation-registry-57089https://curecurrent.com/trials/prostate-cancer-survey-57090https://curecurrent.com/trials/a-prospective-single-center-single-arm-pivotal-trial-of-the-medtronic-hugo-robotic-assisted-surgery-ras-system-57091https://curecurrent.com/trials/physical-therapy-for-men-undergoing-prostatectomy-57092https://curecurrent.com/trials/suturing-techniques-for-vesico-urethral-anastomosis-57093https://curecurrent.com/trials/assessment-of-research-digest-impact-for-minority-with-prostate-cancer-micap-phase-iii-study-57094https://curecurrent.com/trials/mr-fingerprinting-for-diagnostic-of-prostate-cancer-57095https://curecurrent.com/trials/a-study-of-asp1951-in-subjects-with-advanced-solid-tumors-57096https://curecurrent.com/trials/a-study-to-observe-demography-and-the-outcome-of-prostate-cancer-patients-treated-with-6-month-triptorelin-formulation-i-57097https://curecurrent.com/trials/oncological-prognosis-of-prostate-lesions-by-chemical-exchange-saturation-transfer-magnetic-resonance-imaging-cest-mri-57098https://curecurrent.com/trials/a-study-of-copanlisib-in-combination-with-degarelix-in-people-with-prostate-cancer-57099https://curecurrent.com/trials/real-life-study-of-patients-after-3-months-of-leuprorelin-5mg-implant-in-prostate-cancer-57100https://curecurrent.com/trials/a-study-to-compare-the-effect-of-asp3550-with-goserelin-in-patients-with-prostate-cancer-57101https://curecurrent.com/trials/study-to-find-maintenance-dose-for-periodic-administration-of-asp3550-57102https://curecurrent.com/trials/a-study-of-pet-ct-imaging-using-inr101-injection-in-healthy-male-subjects-and-patients-with-suspected-prostate-cancer-57103https://curecurrent.com/trials/artificial-intelligence-models-for-precision-prediction-and-treatment-of-prostate-cancer-57104https://curecurrent.com/trials/rc48-monotherapy-or-combination-with-envafolimab-for-cdk12-alterations-mcrpc-with-standard-treatment-failure-57105https://curecurrent.com/trials/diagnostic-value-of-mri-targeted-plus-index-lesion-ipsilaterally-systematic-biopsy-for-biopsy-naive-men-at-risk-of-prost-57106https://curecurrent.com/trials/pet-scan-study-to-detect-prostate-cancer-in-patients-with-early-psa-recurrence-57107https://curecurrent.com/trials/an-observational-study-to-learn-more-about-the-use-of-darolutamide-as-a-part-of-a-combination-therapy-in-belgian-men-wit-57108https://curecurrent.com/trials/combination-of-turp-and-standard-systemic-therapy-for-mpca-57109https://curecurrent.com/trials/an-investigational-scan-rh-psma-7-3-pet-mri-for-the-detection-of-recurrent-disease-and-aid-in-radiotherapy-planning-in-b-57110https://curecurrent.com/trials/a-study-of-the-absorption-distribution-metabolism-and-elimination-of-opevesostat-mk-5684-in-healthy-adult-male-participa-57111https://curecurrent.com/trials/a-study-evaluating-hc-1119-single-dose-pharmacokinetics-and-effect-of-food-on-its-pharmacokinetics-57112https://curecurrent.com/trials/safety-and-efficacy-evaluation-of-bz371a-topically-applied-on-prostatectomized-patients-57113https://curecurrent.com/trials/adaptive-virtual-consultation-tool-to-enhance-education-and-understanding-in-patients-with-prostate-cancer-57114https://curecurrent.com/trials/fk-pc101-as-adjuvant-therapy-for-men-with-high-risk-prostate-cancer-57115https://curecurrent.com/trials/stockholm3-validation-study-in-a-multi-ethnic-cohort-57116https://curecurrent.com/trials/european-observational-study-of-enzalutamide-in-metastatic-castration-resistant-prostate-cancer-mcrpc-57117https://curecurrent.com/trials/anti-inflammatory-drugs-and-serum-prostate-specific-antigen-test-57118https://curecurrent.com/trials/pk-and-dose-escalation-and-expansion-study-of-dst-2970-57119https://curecurrent.com/trials/trial-of-rucaparib-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-harboring-germline-dna-repair-gene-muta-57120https://curecurrent.com/trials/early-staged-consent-before-prostate-biopsy-57121https://curecurrent.com/trials/checkpoint-inhibitors-and-sbrt-for-mcrpc-57122https://curecurrent.com/trials/high-resolution-diffusion-weighted-imaging-in-prostate-57123https://curecurrent.com/trials/a-drug-drug-interaction-study-of-diltiazem-and-mk-5684-in-healthy-adult-male-participants-mk-5684-011-57124https://curecurrent.com/trials/durvalumab-and-tremelimumab-in-treating-chemotherapy-naive-patients-with-metastatic-castration-resistant-prostate-cancer-57125https://curecurrent.com/trials/threedimensional-multiparametric-ultrasound-for-prostate-cancer-detection-57126https://curecurrent.com/trials/prospective-evaluation-of-proclarix-test-to-improve-risk-stratification-in-men-scheduled-for-mpmri-and-prostate-biopsy-i-57127https://curecurrent.com/trials/phase-1-trial-of-interleukin-12-gene-therapy-for-locally-recurrent-prostate-cancer-57128https://curecurrent.com/trials/dose-escalation-and-efficacy-study-of-lae001-prednisone-plus-afuresertib-patients-with-m-crpc-57129https://curecurrent.com/trials/prostate-cancer-genetic-risk-evaluation-and-screening-study-57130https://curecurrent.com/trials/study-of-docetaxel-combined-with-cirmtuzumab-in-metastatic-castration-resistant-prostate-cancer-57131https://curecurrent.com/trials/the-diagnostic-value-of-fapi-pet-ct-in-staging-of-newly-diagnosed-prostate-cancer-57132https://curecurrent.com/trials/shared-decision-making-prostate-cancer-screening-57133https://curecurrent.com/trials/using-meditation-for-oncology-anxiety-57134https://curecurrent.com/trials/open-label-trial-of-sipuleucel-t-administered-to-active-surveillance-patients-for-newly-diagnosed-prostate-cancer-57135https://curecurrent.com/trials/this-study-is-evaluating-a-new-radiation-treatment-technique-for-patients-who-have-had-prostate-cancer-undergone-surgery-57136https://curecurrent.com/trials/cyberknife-as-monotherapy-or-boost-sbrt-for-intermediate-or-high-risk-localized-prostate-cancer-57137https://curecurrent.com/trials/efficacy-of-a-couple-focused-mhealth-symptom-self-management-program-57138https://curecurrent.com/trials/determination-of-prostate-specific-antigen-in-capillary-blood-psa-cap-57139https://curecurrent.com/trials/partial-prostatectomy-for-prostate-cancer-57140https://curecurrent.com/trials/study-of-89zr-dfo-mstp2109a-in-patients-with-prostate-cancer-57141https://curecurrent.com/trials/64cu-sar-bispsma-for-identification-of-participants-with-recurrence-of-prostate-cancer-cobra-57142https://curecurrent.com/trials/study-to-allow-access-to-pasireotide-for-patients-benefiting-from-pasireotide-treatment-in-novartis-sponsored-studies-57143https://curecurrent.com/trials/sequencing-of-radium-223-and-docetaxel-in-symptomatic-bone-only-metastatic-castration-resistant-prostate-cancer-57144https://curecurrent.com/trials/firmagon-intensive-drug-monitoring-57145https://curecurrent.com/trials/all-in-one-prostate-cancer-staging-with-mri-57146https://curecurrent.com/trials/enzalutamide-vs-abiraterone-in-chemotherapy-na-ve-metastatic-castration-resistant-prostate-cancer-mcrpc-57147https://curecurrent.com/trials/genomics-in-michigan-impacting-observation-or-radiation-57148https://curecurrent.com/trials/combination-study-of-azd5069-and-enzalutamide-57149https://curecurrent.com/trials/68ga-aazta-ni-093-pet-ct-first-in-human-study-57150https://curecurrent.com/trials/addition-of-opaganib-to-androgen-antagonists-in-patients-with-mcrpc-57151https://curecurrent.com/trials/18f-rhpsma-7-3-pet-mri-in-prostate-cancer-active-surveillance-a-pilot-study-57152https://curecurrent.com/trials/prostate-imaging-using-mri-contrast-enhancement-57153https://curecurrent.com/trials/a-study-of-extending-relugolix-dosing-intervals-through-addition-of-itraconazole-or-ritonavir-in-prostate-cancer-patient-57154https://curecurrent.com/trials/nerve-grafting-technique-to-preserve-erectile-function-in-patients-undergoing-robotic-assisted-radical-prostatectomy-57155https://curecurrent.com/trials/a-trial-of-5-fraction-prostate-sbrt-versus-5-fraction-prostate-and-pelvic-nodal-sbrt-57156https://curecurrent.com/trials/model-of-predicting-biochemical-recurrence-after-radical-prostate-cancer-based-on-pre-treatment-psma-pet-mr-image-featur-57157https://curecurrent.com/trials/sleep-exercise-nutrition-and-survivorship-in-prostate-cancer-57158https://curecurrent.com/trials/developing-an-imaging-based-tool-to-identify-areas-for-prostate-cancer-biopsy-57159https://curecurrent.com/trials/177lu-psma-niraparib-aa-plus-prednisone-for-prostate-cancer-57160https://curecurrent.com/trials/prostatic-size-reduction-following-of-leuprorelin-acetate-57161https://curecurrent.com/trials/psma-pet-ct-for-prostate-cancer-57162https://curecurrent.com/trials/evaluating-race-specific-age-accumulation-as-a-behavioral-biomarker-prostate-cancer-survivors-57163https://curecurrent.com/trials/finasteride-and-flutamide-in-pre-surgical-trial-in-prostate-cancer-57164https://curecurrent.com/trials/correlation-between-prostate-specific-membrane-antigen-positron-emission-tomography-and-arterial-spin-labeling-perfusion-57165https://curecurrent.com/trials/towards-optimal-treatment-for-high-risk-prostate-cancer-57166https://curecurrent.com/trials/genetic-and-molecular-mechanisms-in-assessing-response-in-patients-with-prostate-cancer-receiving-enzalutamide-therapy-57167https://curecurrent.com/trials/conventional-androgen-deprivation-therapy-adt-with-or-without-abiraterone-acetate-prednisone-and-apalutamide-following-a-57168https://curecurrent.com/trials/strength-aging-and-memory-in-prostate-cancer-57169https://curecurrent.com/trials/18f-psma-1007-pet-ct-imaging-in-patients-with-biochemically-recurrent-or-high-risk-prostate-cancer-57170https://curecurrent.com/trials/to-live-better-after-prostate-cancer-treatment-57171https://curecurrent.com/trials/a-yoga-program-for-patients-undergoing-prostate-cancer-surgery-57172https://curecurrent.com/trials/de-implementation-of-low-value-castration-for-men-with-prostate-cancer-57173https://curecurrent.com/trials/metastasis-directed-therapy-in-oligoprogressive-castration-refractory-prostate-cancer-57174https://curecurrent.com/trials/circulating-tumor-dna-ctdna-monitoring-in-the-assessment-and-prediction-of-the-efficacy-of-parp-inhibitors-parpi-57175https://curecurrent.com/trials/intramuscular-mechanisms-of-androgen-deprivation-related-sarcopenia-57176https://curecurrent.com/trials/combination-of-serum-measurements-of-molecular-biomarkers-and-serum-protein-profiling-can-be-used-to-predict-which-patie-57177https://curecurrent.com/trials/evaluation-of-different-methods-of-ultrasound-image-analysis-for-real-time-monitoring-of-hifu-prostate-cancer-treatment-57178https://curecurrent.com/trials/study-of-tas3681-in-metastatic-castration-resistant-prostate-cancer-57179https://curecurrent.com/trials/biodistribution-reproducibility-ga-68-psma-hbed-cc-57180https://curecurrent.com/trials/study-of-odx-osteodex-in-metastatic-castration-resistant-prostate-cancer-crpc-57181https://curecurrent.com/trials/radiation-therapy-and-docetaxel-in-treating-patients-who-are-undergoing-surgery-for-localized-prostate-cancer-57182https://curecurrent.com/trials/a-first-step-towards-ultra-hypofractionation-for-unfavourable-intermediate-and-high-risk-prostate-cancer-57183https://curecurrent.com/trials/trial-of-adt-and-sbrt-versus-sbrt-for-intermediate-prostate-cancer-57184https://curecurrent.com/trials/using-virtual-reality-vr-models-for-robotic-prostatectomy-unc-57185https://curecurrent.com/trials/neoadjuvant-therapy-of-darolutamide-plus-adt-for-high-risk-prostate-cancer-57186https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-relapsed-prostate-cancer-after-surgery-57187https://curecurrent.com/trials/stockholm3-use-prior-to-mri-for-prostate-cancer-detection-in-a-clinical-care-pathway-a-multi-centered-validation-57188https://curecurrent.com/trials/digitally-captured-activity-data-and-pros-to-monitor-physical-function-in-prostate-cancer-patients-57189https://curecurrent.com/trials/feasibility-of-technology-based-ssip-in-prostate-cancer-patients-57190https://curecurrent.com/trials/radical-hypofractionated-radiotherapy-for-localized-prostate-cancer-57191https://curecurrent.com/trials/national-robotics-assisted-radical-prostatectomy-database-57192https://curecurrent.com/trials/hypofractionated-post-prostatectomy-radiotherapy-hyport-for-localized-prostate-cancer-57193https://curecurrent.com/trials/a-rollover-study-for-patients-who-received-tremelimumab-in-other-protocols-to-allow-the-patients-access-to-tremelimumab-57194https://curecurrent.com/trials/can-mri-of-the-prostate-combined-with-a-radiomics-evaluation-determine-the-invasive-capacity-of-a-tumour-57195https://curecurrent.com/trials/a-feasibility-study-of-an-online-intervention-for-sexual-rehabilitation-in-prostate-cancer-57196https://curecurrent.com/trials/resist-adt-androgen-deprivation-therapy-57197https://curecurrent.com/trials/artemis-003-hs-20093-in-patients-with-metastatic-castrate-resistant-prostate-cancer-mcrpc-and-advanced-solid-tumors-57198https://curecurrent.com/trials/pro-mr-rt-systematic-patient-reported-outcomes-to-pelvic-online-mrgrt-57199https://curecurrent.com/trials/comparison-of-nerve-sparing-techniques-in-radical-prostatectomy-for-oncological-outcome-and-functional-recovery-57200https://curecurrent.com/trials/psma-specific-68ga-p137-peptide-probe-for-pet-imaging-in-prostate-cancer-57201https://curecurrent.com/trials/hc-1119-versus-enzalutamide-in-metastatic-castration-resistant-prostate-cancer-mcrpc-57202https://curecurrent.com/trials/non-inferiority-randomized-controlled-trial-of-cognitive-targeted-biopsy-versus-software-targeted-biopsy-57203https://curecurrent.com/trials/clinical-study-of-hifu-for-localized-prostate-cancer-57204https://curecurrent.com/trials/targeted-radionuclide-therapy-in-metastatic-prostate-cancer-using-a-new-psma-ligand-radiolabelled-with-terbium-161-161tb-57205https://curecurrent.com/trials/prct002-prostate-cancer-treatment-with-the-aquabeam-robotic-system-57206https://curecurrent.com/trials/study-of-nerve-reconstruction-using-avance-in-subjects-who-undergo-robotic-assisted-prostatectomy-for-treatment-of-prost-57207https://curecurrent.com/trials/prostatic-artery-embolization-for-the-treatment-of-lower-urinary-tract-symptoms-in-prostate-cancer-patients-undergoing-r-57208https://curecurrent.com/trials/binaural-sound-for-remimazolam-maintenance-57209https://curecurrent.com/trials/study-of-177lu-lu-psma-137-in-metastatic-castrate-resistant-prostate-cancer-mcrpc-57210https://curecurrent.com/trials/assessments-of-genetic-counseling-augmented-with-an-educational-video-or-pamphlet-versus-traditional-counseling-57211https://curecurrent.com/trials/a-study-of-atezolizumab-anti-pd-l1-antibody-in-combination-with-enzalutamide-in-participants-with-metastatic-castration-57212https://curecurrent.com/trials/the-role-of-levator-ani-muscle-reconstruction-technology-in-urinary-incontinence-recovery-57213https://curecurrent.com/trials/radiotherapy-assessments-during-intervention-and-treatment-radiant-57214https://curecurrent.com/trials/a-study-of-high-risk-localized-prostate-cancer-participants-treated-with-radical-prostatectomy-and-perioperative-hormona-57215https://curecurrent.com/trials/observation-of-clinical-consistency-of-organoid-chips-drug-sensitivity-in-chemotherapy-for-pca-with-visceral-metastasis-57216https://curecurrent.com/trials/the-impact-of-medication-timing-adjustment-on-the-effect-of-novel-hormonal-therapy-57217https://curecurrent.com/trials/safety-of-sgi-1776-a-pim-kinase-inhibitor-in-refractory-prostate-cancer-and-relapsed-refractory-non-hodgkin-s-lymphoma-57218https://curecurrent.com/trials/a-study-of-hsp90-inhibitor-at13387-alone-or-in-combination-with-abiraterone-acetate-57219https://curecurrent.com/trials/luteinizing-hormone-releasing-hormone-analogue-and-enzalutamide-zoledronic-acid-in-prostate-cancer-patients-57220https://curecurrent.com/trials/my-health-day-by-day-mi-salud-dia-a-dia-57221https://curecurrent.com/trials/open-label-dose-escalation-phase-1b-trial-of-a-new-micellar-docetaxel-compound-in-patients-with-mcrpc-57222https://curecurrent.com/trials/pchip-prostate-cancer-health-impact-program-57223https://curecurrent.com/trials/efficacy-and-safety-of-organoid-based-drug-sensitivity-screening-to-guide-the-treatment-of-mcrpc-patients-progressed-aft-57224https://curecurrent.com/trials/multiparametric-assessment-of-bone-response-in-mcrpc-patients-treated-with-cabozantinib-57225https://curecurrent.com/trials/transpelvic-magnetic-stimulation-to-improve-urogenital-function-57226https://curecurrent.com/trials/multispectral-fluorescence-as-a-tool-to-separate-healthy-and-disease-related-lymphatic-anatomies-in-prostate-cancer-57227https://curecurrent.com/trials/the-safety-and-dosimetry-study-of-177lu-lnc1003-injection-57228https://curecurrent.com/trials/two-fraction-ultrahypofractionated-radiotherapy-with-focal-boost-for-intermediate-risk-localized-prostate-cancer-57229https://curecurrent.com/trials/tracking-peripheral-blood-mononuclear-cells-with-fluorine-mri-57230https://curecurrent.com/trials/teverelix-evaluated-in-advanced-prostate-cancer-57231https://curecurrent.com/trials/technologies-to-improve-qol-of-prostate-cancer-57232https://curecurrent.com/trials/comparison-of-the-effectiveness-of-supervised-video-based-and-home-based-resistance-exercise-program-in-patients-with-pr-57233https://curecurrent.com/trials/a-combined-programme-of-exercise-and-dietary-advice-in-men-with-castrate-resistant-prostate-cancer-57234https://curecurrent.com/trials/reconstitution-of-a-human-immune-system-in-a-patient-derived-xenograft-pdx-model-of-genitourinary-gu-cancers-57235https://curecurrent.com/trials/study-to-gather-information-on-the-safety-and-how-radium-223-dichloride-an-alpha-particle-emitting-radioactive-agent-wor-57236https://curecurrent.com/trials/the-application-value-of-prostate-specific-membrane-antigen-pet-ct-in-biopsy-free-of-psa-grey-area-prostate-cancer-57237https://curecurrent.com/trials/fus-tb-vs-cog-tb-in-small-lesions-of-prostate-cancer-57238https://curecurrent.com/trials/esk981-and-nivolumab-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-57239https://curecurrent.com/trials/darxicilib-combined-with-abiraterone-acetate-tablets-ii-for-the-treatment-of-advanced-metastatic-castration-resistant-pr-57240https://curecurrent.com/trials/correlation-between-psa-levels-and-f-18-psma-pet-ct-findings-in-prostate-cancer-patient-57241https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-plus-docetaxel-versus-placebo-plus-docetaxel-in-chemotherapy-na-ve-metastatic-castration-57242https://curecurrent.com/trials/68ga-psma-pet-for-patients-with-biochemical-recurrence-of-prostate-cancer-57243https://curecurrent.com/trials/177lu-psma-eb-01-in-patients-with-metastatic-castration-resistant-prostate-cancer-57244https://curecurrent.com/trials/68ga-psma-pet-mri-in-conjunction-with-mpmri-for-evaluating-prospective-prostate-cancer-risk-57245https://curecurrent.com/trials/avelumab-plus-2nd-generation-adt-in-african-american-subjects-with-mcrpc-57246https://curecurrent.com/trials/tendu-vaccine-in-patients-with-relapse-after-primary-radical-prostatectomy-57247https://curecurrent.com/trials/prospective-asian-multicenter-prostate-cancer-focal-therapy-study-proamfocal-57248https://curecurrent.com/trials/prostate-cancer-18f-psma-1007-pet-ct-access-trial-57249https://curecurrent.com/trials/vmat-for-dominant-intraprostatic-lesion-57250https://curecurrent.com/trials/trial-to-investigate-the-benefit-of-elective-para-aortic-radiotherapy-part-for-pn1-prostate-cancer-57251https://curecurrent.com/trials/68ga-psma-11-efficacy-in-detecting-bcr-prostate-cancer-in-chinese-patients-57252https://curecurrent.com/trials/heterogeneity-of-tertiary-lymphoid-structures-predicts-distinct-malignancy-and-immune-microenvironment-in-prostate-cance-57253https://curecurrent.com/trials/mri-targeted-biopsy-of-the-prostate-software-versus-visual-registration-in-the-accuracy-of-prostate-cancer-detection-57254https://curecurrent.com/trials/high-precision-imaging-of-prostate-specific-membrane-antigen-for-personalized-treatment-in-prostate-cancer-57255https://curecurrent.com/trials/metastasis-directed-therapy-for-oligorecurrent-prostate-cancer-57256https://curecurrent.com/trials/neoadjuvant-degarelix-with-or-without-apalutamide-arn-509-followed-by-radical-prostatectomy-57257https://curecurrent.com/trials/dendritic-cell-vaccination-and-docetaxel-for-patients-with-prostate-cancer-57258https://curecurrent.com/trials/pet-mri-to-stage-prostate-cancer-patients-57259https://curecurrent.com/trials/evaluation-of-clinical-outcomes-of-chemotherapy-or-androgen-receptor-targeting-agent-alone-or-combined-or-radiotherapy-o-57260https://curecurrent.com/trials/comprehensive-yoga-program-sky-as-adjunct-therapy-for-prostate-cancer-57261https://curecurrent.com/trials/abemaciclib-ly2835219-in-men-with-heavily-treated-metastatic-castration-resistant-prostate-cancer-57262https://curecurrent.com/trials/a-study-to-establish-the-feasibility-of-biolen-for-the-local-delivery-of-bicalutamide-in-patients-with-prostate-cancer-57263https://curecurrent.com/trials/safety-of-dose-escalation-in-definitive-hypofractionated-radiation-therapy-and-hormone-therapy-with-spaceoar-tm-for-pati-57264https://curecurrent.com/trials/targeted-cryoablation-of-prostate-cancer-lesions-an-investigator-initiated-trial-57265https://curecurrent.com/trials/safety-of-dose-escalation-in-definitive-hypofractionated-radiation-therapy-with-spaceoar-tm-for-patients-with-low-to-int-57266https://curecurrent.com/trials/an-open-label-study-of-the-effect-of-tomivosertib-eft508-in-patients-with-advanced-castrate-resistant-prostate-cancer-57267https://curecurrent.com/trials/adjuvant-apalutamide-in-subjects-with-high-risk-localized-or-locally-advanced-prostate-cancer-after-radical-prostatectom-57268https://curecurrent.com/trials/a-study-of-nox66-and-external-beam-radiotherapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-and-oth-57269https://curecurrent.com/trials/intervention-study-in-prostate-cancer-patients-undergoing-radiotherapy-57270https://curecurrent.com/trials/head-to-head-comparison-of-18f-f-psma-n5-with-68ga-ga-psma-11-pet-ct-in-pca-diagnosis-recurrence-and-metastasis-57271https://curecurrent.com/trials/head-to-head-comparison-of-18f-f-psma-n5-with-18f-f-psma-1007-pet-ct-in-pca-diagnosis-recurrence-and-metastasis-57272https://curecurrent.com/trials/to-evaluate-the-effect-of-mcs-in-prostate-cancer-prevention-57273https://curecurrent.com/trials/phase-i-trial-of-225ac-j591-in-patients-with-mcrpc-57274https://curecurrent.com/trials/hb-302-hb-301-therapy-in-participants-with-metastatic-castration-resistant-prostate-cancer-57275https://curecurrent.com/trials/comparing-portable-mri-and-trus-fusion-prostate-biopsy-to-assess-accuracy-of-prostate-cancer-detection-57276https://curecurrent.com/trials/effect-of-a-reduced-dose-enzalutamide-in-frail-m-crpc-patients-on-cognitive-side-effects-57277https://curecurrent.com/trials/pembrolizumab-carboplatin-and-cabazitaxel-in-aggressive-metastatic-castration-resistant-prostate-cancer-peapod-fos-57278https://curecurrent.com/trials/training-for-men-undergoing-androgen-deprivation-therapy-57279https://curecurrent.com/trials/leveraging-technology-to-achieve-equity-for-men-with-prostate-cancer-on-androgen-deprivation-therapy-57280https://curecurrent.com/trials/cisplatin-in-castration-resistant-prostate-cancer-57281https://curecurrent.com/trials/diagnostic-accuracy-and-performance-of-18f-psma-1007-57282https://curecurrent.com/trials/18f-psma-pet-and-mri-in-the-primary-staging-of-prostate-cancer-patients-57283https://curecurrent.com/trials/neoadjuvant-ipilimumab-in-prostate-cancer-57284https://curecurrent.com/trials/multi-modal-image-fusion-for-precision-prostate-biopsy-navigation-57285https://curecurrent.com/trials/using-virtual-reality-vr-models-for-robotic-prostatectomy-57286https://curecurrent.com/trials/pet-scan-in-treating-patients-with-metastatic-prostate-cancer-57287https://curecurrent.com/trials/oral-docetaxel-modradoc-r-in-combination-with-hormonal-treatment-and-radiation-therapy-in-high-risk-prostate-cancer-57288https://curecurrent.com/trials/clinical-investigation-of-the-da-vinci-surgical-system-57289https://curecurrent.com/trials/a-prospective-randomized-trial-comparing-office-based-mr-guided-prostate-biopsy-approaches-57290https://curecurrent.com/trials/prostvac-in-combination-with-nivolumab-in-men-with-prostate-cancer-57291https://curecurrent.com/trials/68ga-aazta-093-pet-ct-first-in-human-study-57292https://curecurrent.com/trials/efficacy-and-safety-of-darolutamide-in-combination-with-androgen-deprivation-therapy-in-prostate-cancer-patients-with-ly-57293https://curecurrent.com/trials/addition-of-enzalutamide-to-first-line-docetaxel-for-castration-resistant-prostate-cancer-57294https://curecurrent.com/trials/effect-of-hypoxia-on-fmiso-pet-to-response-to-lu-177-psma-treatment-57295https://curecurrent.com/trials/perioperative-propranolol-during-prostatectomy-to-decrease-cancer-recurrence-57296https://curecurrent.com/trials/feasibility-study-educational-genetic-test-video-57297https://curecurrent.com/trials/pilot-study-of-vti-doppler-probe-use-to-identify-neurovascular-bundle-during-prostate-surgery-57298https://curecurrent.com/trials/outcomes-of-local-treatment-for-oligometastatic-prostate-cancer-diagnosed-using-psma-pet-imaging-oligomet-study-57299https://curecurrent.com/trials/sodium-selenite-and-radiation-therapy-in-treating-patients-with-metastatic-cancer-57300https://curecurrent.com/trials/the-long-term-effect-of-mri-before-radical-prostatectomy-57301https://curecurrent.com/trials/effect-of-lidocaine-gel-and-cold-lidocaine-gel-on-pain-in-patients-who-had-prostate-biopsy-with-transrectal-ultrasound-57302https://curecurrent.com/trials/microbiome-molecular-charaterisation-57303https://curecurrent.com/trials/role-of-rhpsma-7-3-pet-ct-imaging-in-men-with-high-risk-prostate-cancer-following-conventional-imaging-and-associated-ch-57304https://curecurrent.com/trials/t-cell-responses-to-neoantigens-post-treatment-with-ipilimumab-in-men-with-metastatic-castration-resistant-prostate-canc-57305https://curecurrent.com/trials/trial-of-community-health-worker-led-decision-coaching-57306https://curecurrent.com/trials/adaptive-mr-guided-sbrt-for-localized-prostate-cancer-57307https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-high-risk-prostate-cancer-undergoing-surgery-57308https://curecurrent.com/trials/disitamab-vedotin-in-the-treatment-with-her2-expression-subjects-with-locally-advanced-or-metastatic-castration-resistan-57309https://curecurrent.com/trials/prospective-comparative-study-for-patients-with-biochemical-recurrence-prostate-cancer-detecting-by-18f-jk-psma-7-57310https://curecurrent.com/trials/prospective-prostate-cancer-and-patient-reported-outcomes-registry-57311https://curecurrent.com/trials/rad-1801-pilot-study-of-intra-urethral-radiotransponder-beacon-guided-focal-prostate-stereotactic-body-radiotherapy-57312https://curecurrent.com/trials/automatic-detection-in-mri-of-prostate-cancer-daicap-57313https://curecurrent.com/trials/sleep-hygiene-education-readiwatchtm-actigraphy-and-telehealth-cognitive-behavioral-training-for-insomnia-effect-on-symp-57314https://curecurrent.com/trials/antibody-cc-1-in-men-with-biochemical-recurrence-of-prostate-cancer-57315https://curecurrent.com/trials/digital-pet-ct-using-ga-68-psma-vs-f-18-naf-for-evaluation-of-osseous-metastatic-involvement-in-prostate-cancer-patients-57316https://curecurrent.com/trials/the-effect-of-tens-on-pain-complications-and-comfort-in-patients-who-had-prostate-biopsy-with-transrectal-ultrasound-57317https://curecurrent.com/trials/goal-directed-vs-preemptive-tranexamic-acid-administration-in-non-cardiac-surgery-57318https://curecurrent.com/trials/randomized-phase-ii-study-of-salvage-xrt-adt-abiraterone-and-apalutamide-for-rising-psa-after-rp-formula-509-57319https://curecurrent.com/trials/prostate-cancer-radiotherapy-bowel-quality-of-life-procar-bq-57320https://curecurrent.com/trials/effects-of-kieser-resistance-training-plus-kieser-pelvic-floor-training-vs-kieser-resistance-training-plus-traditional-p-57321https://curecurrent.com/trials/magnetic-resonance-guided-focal-stereotactic-body-radiation-therapy-for-localized-prostate-cancer-57322https://curecurrent.com/trials/comparing-bp-mri-and-mp-mri-for-prostate-cancer-screening-accuracy-57323https://curecurrent.com/trials/mencore-2-audio-recordings-to-improve-decision-making-in-advanced-prostate-cancer-57324https://curecurrent.com/trials/feasibility-study-on-the-use-of-pet-mri-68ga-psma-imaging-for-hifu-focal-treatment-in-the-event-of-recurrent-prostate-ca-57325https://curecurrent.com/trials/catch-r-a-rollover-study-to-provide-continued-access-to-rucaparib-57326https://curecurrent.com/trials/biobank-and-register-of-patients-with-agresive-tumors-for-translational-and-analytical-research-57327https://curecurrent.com/trials/observational-study-of-patients-who-underwent-diagnostic-investigation-prostate-biopsy-and-or-radical-prostatectomy-surg-57328https://curecurrent.com/trials/daratumumab-or-fms-inhibitor-jnj-40346527-before-surgery-in-treating-patients-with-high-risk-resectable-localized-or-loc-57329https://curecurrent.com/trials/neoadjuvant-listeria-or-daratumumab-in-prostate-cancer-57330https://curecurrent.com/trials/study-of-177lu-lu-xt033-injection-in-patients-with-metastatic-prostate-cancer-57331https://curecurrent.com/trials/pilot-trial-of-chemohormonal-therapy-followed-by-prostatectomy-in-high-risk-prostate-cancer-57332https://curecurrent.com/trials/68ga-psma-pet-ct-in-prostate-cancer-57333https://curecurrent.com/trials/hypofractionated-sbrt-for-prostate-cancer-57334https://curecurrent.com/trials/64cu-tlx592-phase-i-safety-pk-biodistribution-and-dosimetry-study-cupid-study-57335https://curecurrent.com/trials/a-pilot-study-of-5-aza-and-atra-for-prostate-cancer-with-psa-only-recurrence-after-local-treatment-57336https://curecurrent.com/trials/lu-177-ludotadipep-in-castration-resistant-prostate-cancer-crpc-investigation-of-drug-and-application-2-57337https://curecurrent.com/trials/lu-177-ludotadipep-in-castration-resistant-prostate-cancer-crpc-investigation-of-drug-and-application-57338https://curecurrent.com/trials/exploration-of-the-value-of-psma-pet-ct-in-dynamic-monitoring-of-the-efficacy-of-novel-endocrine-therapy-in-patients-wit-57339https://curecurrent.com/trials/genomic-biomarker-guided-neoadjuvant-therapy-for-prostate-cancer-segno-57340https://curecurrent.com/trials/to-assess-the-patient-preference-for-goserelin-microsphere-versus-goserelin-implant-in-patients-with-prostate-cancer-57341https://curecurrent.com/trials/characterization-of-prostate-cancer-with-3t-mr-57342https://curecurrent.com/trials/psma-pet-mri-for-radiation-treatment-planning-in-patients-with-locally-metastatic-prostate-cancer-a-pilot-study-57343https://curecurrent.com/trials/comparison-of-analgesia-efficacy-of-transversus-abdominis-plane-block-and-posterior-approach-quadratus-lumborum-block-57344https://curecurrent.com/trials/randomized-trial-of-trust-in-online-videos-about-prostate-cancer-57345https://curecurrent.com/trials/choline-metabolites-in-people-with-prostate-cancer-and-those-with-benign-hyperplasia-57346https://curecurrent.com/trials/abiraterone-acetate-in-combination-with-tildrakizumab-57347https://curecurrent.com/trials/the-effect-of-ibd-flares-on-serum-psa-57348https://curecurrent.com/trials/is-the-hifem-procedure-an-effective-treatment-for-men-with-post-prostatectomy-incontinence-57349https://curecurrent.com/trials/dose-escalating-trial-with-unicar02-t-cells-and-psma-target-module-tmppsma-in-patients-with-progressive-disease-after-st-57350https://curecurrent.com/trials/data-collection-in-lutetium-treated-prostate-cancer-recording-of-progression-and-tumor-characteristics-57351https://curecurrent.com/trials/phase-ii-dose-finding-study-of-gtx-758-57352https://curecurrent.com/trials/modradoc006-r-vs-docetaxel-iv-in-metastatic-prostate-cancer-57353https://curecurrent.com/trials/interactive-decision-aid-for-men-diagnosed-with-prostate-cancer-57354https://curecurrent.com/trials/decade-long-insights-into-transperineal-prostate-biopsy-in-a-west-china-population-57355https://curecurrent.com/trials/an-open-label-phase-ii-study-of-azd4635-in-patients-with-prostate-cancer-57356https://curecurrent.com/trials/biomarker-analysis-of-castration-resistant-prostate-cancer-undergoing-treatment-with-docetaxel-followed-by-enzalutamide-57357https://curecurrent.com/trials/stereotactic-ablative-radiation-therapy-for-abiraterone-resistant-oligoprogressive-metastatic-prostate-cancer-57358https://curecurrent.com/trials/platform-study-for-prostate-researching-translational-endpoints-correlated-to-response-to-inform-use-of-novel-combinatio-57359https://curecurrent.com/trials/study-of-pcur-101-in-combination-with-adt-in-patients-with-mcrpc-57360https://curecurrent.com/trials/clinical-applications-of-integrated-pet-mr-and-pet-ct-in-the-diagnosis-and-treatment-of-prostate-cancer-57361https://curecurrent.com/trials/new-urethral-reconstruction-in-robot-assisted-laparoscopic-radical-resection-57362https://curecurrent.com/trials/a-study-of-olaparib-and-durvalumab-in-prostate-cancer-57363https://curecurrent.com/trials/an-observational-study-to-learn-more-about-the-use-of-androgen-receptor-inhibitors-and-how-they-affect-men-with-nonmetas-57364https://curecurrent.com/trials/effect-of-optimized-peep-on-mechanical-ventilation-during-robot-assisted-laparoscopic-prostatectomy-57365https://curecurrent.com/trials/cytoreductive-prostatectomy-combined-with-triple-or-dual-systemic-therapy-in-mhspc-patients-57366https://curecurrent.com/trials/ultrasound-for-detection-of-prostate-cancer-57367https://curecurrent.com/trials/a-study-evaluating-the-safety-pharmacokinetics-and-clinical-effects-of-intravenously-administered-pt-112-injection-in-su-57368https://curecurrent.com/trials/a-study-of-talazoparib-in-men-with-dna-repair-defects-and-metastatic-castration-resistant-prostate-cancer-57369https://curecurrent.com/trials/modified-radical-prostatectomy-for-prostate-cancer-patients-with-enlarged-prostate-and-severe-lower-urinary-tract-sympto-57370https://curecurrent.com/trials/randomized-pilot-study-of-radiosurgery-for-the-treatment-of-non-metastatic-prostate-cancer-57371https://curecurrent.com/trials/randomized-controlled-trial-of-mri-target-biopsy-transrectal-vs-transperineal-57372https://curecurrent.com/trials/validating-the-sexual-minorities-and-prostate-cancer-scale-to-gold-standard-questionnaires-57373https://curecurrent.com/trials/phase-1-study-evaluating-safety-and-tolerability-of-sl-t10-gx-i7-and-pembrolizumab-triple-combination-in-mcrpc-57374https://curecurrent.com/trials/high-resolution-mri-study-for-prostate-cancer-57375https://curecurrent.com/trials/adxs31-142-alone-and-in-combination-with-pembrolizumab-mk-3475-in-participants-with-previously-treated-metastatic-castra-57376https://curecurrent.com/trials/n-803-alone-or-in-combination-with-bn-brachyury-vaccine-or-bintrafusp-alfa-m7824-for-participants-with-castration-resist-57377https://curecurrent.com/trials/restore-improving-sexual-outcomes-of-gay-and-bisexual-prostate-cancer-survivors-57378https://curecurrent.com/trials/intratumoral-and-systemic-hiltonol-poly-iclc-in-prostate-cancer-patients-on-active-surveillance-57379https://curecurrent.com/trials/adjuvant-hypofractionated-radiotherapy-for-prostate-cancer-57380https://curecurrent.com/trials/image-guided-focal-dose-escalation-primary-pc-treated-with-primary-external-beam-hypofract-stereotactic-rt-57381https://curecurrent.com/trials/comparison-of-the-effectiveness-of-different-conservative-treatment-protocols-in-postprostatectomy-urinary-incontinence-57382https://curecurrent.com/trials/the-pc-light-study-57383https://curecurrent.com/trials/hypofractionated-radiosurgery-for-localised-prostate-cancer-57384https://curecurrent.com/trials/psma-pet-mri-low-and-intermediate-risk-prostate-cancer-57385https://curecurrent.com/trials/a-trial-of-ctt1403-for-metastatic-castration-resistant-prostate-cancer-57386https://curecurrent.com/trials/toxicity-comparison-between-hypofractionated-radiotherapy-with-hdr-brachytherapy-boost-versus-standard-treatment-57387https://curecurrent.com/trials/a-study-to-assess-the-safety-pharmacokinetics-and-anti-tumor-activity-of-oral-hp518-in-patients-with-metastatic-castrati-57388https://curecurrent.com/trials/hypofractionated-radiosurgery-for-localised-prostate-cancer-hypostat-ii-57389https://curecurrent.com/trials/response-evaluation-of-cancer-therapeutics-in-metastatic-castration-resistant-prostate-cancer-to-the-bone-57390https://curecurrent.com/trials/civasheet-with-radical-prostatectomy-adjuvant-external-beam-radiation-57391https://curecurrent.com/trials/an-observational-study-called-dear-to-learn-more-about-treatment-with-darolutamide-enzalutamide-and-apalutamide-in-men-w-57392https://curecurrent.com/trials/promise-pet-registry-on-psma-pet-and-outcome-in-prostate-cancer-57393https://curecurrent.com/trials/artificial-intelligence-3d-augmented-reality-robot-assisted-radical-prostatectomy-v-s-no3d-intervention-57394https://curecurrent.com/trials/a-salvage-trial-of-ar-inhibition-with-adt-and-apalutamide-with-radiation-therapy-followed-by-docetaxel-in-men-with-psa-r-57395https://curecurrent.com/trials/a-study-of-adaptive-radiation-therapy-for-pelvic-genitourinary-cancer-57396https://curecurrent.com/trials/prostatectomy-adaptive-radiation-therapy-art-57397https://curecurrent.com/trials/fiducial-localization-and-individualized-radiotherapy-prostate-cancer-57398https://curecurrent.com/trials/vitamin-d3-supplementation-for-low-risk-prostate-cancer-a-randomized-trial-57399https://curecurrent.com/trials/effect-of-casodex-on-tumour-hypoxia-prostate-cancer-57400https://curecurrent.com/trials/an-evaluation-of-the-efficacy-and-safety-of-apalutamide-as-neoadjuvant-endocrine-therapy-in-high-risk-and-oligometastati-57401https://curecurrent.com/trials/a-neoadjuvant-study-of-abiraterone-acetate-leuprolide-acetate-and-belzutifan-in-men-with-regional-prostate-cancer-57402https://curecurrent.com/trials/study-to-assess-abivertinib-in-combination-with-abiraterone-in-metastatic-castration-resistant-prostate-cancer-57403https://curecurrent.com/trials/efficacy-and-safety-of-apalutamide-in-combination-with-89sr-as-neoadjuvant-therapy-in-prostate-cancer-with-10-bone-metas-57404https://curecurrent.com/trials/comparison-of-spinal-anesthesia-and-spermatic-cord-block-for-bilateral-orchiectomy-57405https://curecurrent.com/trials/rucaparib-in-nonmetastatic-prostate-with-brcaness-57406https://curecurrent.com/trials/odm-201-maintenance-therapy-in-patients-with-mcrpc-previously-treated-with-novel-hormonal-agents-57407https://curecurrent.com/trials/primary-care-based-follow-up-of-cancer-survivors-of-the-prostate-and-kidney-57408https://curecurrent.com/trials/evaluation-of-darolutamide-addition-to-androgen-deprivation-therapy-and-radiation-therapy-in-newly-diagnosed-prostate-ca-57409https://curecurrent.com/trials/salvage-radiotherapy-combined-with-androgen-deprivation-therapy-adt-with-or-without-rezvilutamide-in-the-treatment-of-bi-57410https://curecurrent.com/trials/bleeding-after-robot-assisted-radical-prostatectomy-a-respective-study-57411https://curecurrent.com/trials/a-study-to-learn-more-about-how-radium-223-is-being-used-with-other-treatments-in-european-patients-who-have-not-receive-57412https://curecurrent.com/trials/gallium-68-psma-11-pet-in-participants-with-prostate-cancer-57413https://curecurrent.com/trials/11c-choline-pet-ct-based-helical-tomotherapy-as-innovative-treratment-approach-for-bone-metastases-in-prostate-cancer-pa-57414https://curecurrent.com/trials/using-tissue-based-spatial-data-to-understand-how-obesity-related-tumor-metabolites-fuel-prostate-cancer-progression-57415https://curecurrent.com/trials/ketoconazole-with-or-without-alendronate-sodium-in-treating-patients-with-metastatic-prostate-cancer-57416https://curecurrent.com/trials/radiation-therapy-in-combination-with-brachytherapy-for-clinically-localized-intermediate-risk-prostate-cancer-57417https://curecurrent.com/trials/evaluation-of-the-technical-feasibility-of-testing-ct-dna-for-homologous-recombination-gene-variants-in-metastatic-prost-57418https://curecurrent.com/trials/dose-escalation-with-sib-to-intraprostatic-lymphatic-gtv-in-high-risk-prostate-cancer-57419https://curecurrent.com/trials/testing-an-e-health-intervention-for-prostate-cancer-survivors-mental-and-sexual-health-57420https://curecurrent.com/trials/a-phase-i-study-to-assess-psma-and-psma-tumour-lesions-57421https://curecurrent.com/trials/docetaxel-alone-or-in-combination-with-enzalutamide-for-mcrpc-previously-treated-with-abiraterone-at-mhspc-stage-57422https://curecurrent.com/trials/multi-modality-prostate-cancer-image-guided-interventions-57423https://curecurrent.com/trials/stereotactic-body-radiotherapy-with-or-without-darolutamide-for-oligorecurrent-prostate-cancer-57424https://curecurrent.com/trials/different-fractionation-schedules-of-radiotherapy-to-the-primary-tumour-in-metastatic-hormone-sensitive-prostate-cancer-57425https://curecurrent.com/trials/investigating-the-safety-tolerability-and-efficacy-of-amorphous-calcium-carbonate-acc-on-the-treatment-of-subjects-with-57426https://curecurrent.com/trials/michl-trial-impact-of-peritoneal-bladder-flap-in-rarp-patients-on-lymphoceles-57427https://curecurrent.com/trials/tolerability-palatability-of-talitytm-synthetic-meal-replacement-in-prostate-cancer-57428https://curecurrent.com/trials/evaluating-the-role-of-ultrasound-in-prostate-cancer-57429https://curecurrent.com/trials/psma-pet-guided-hypofractionated-salvage-prostate-bed-radiotherapy-57430https://curecurrent.com/trials/feasibility-of-virtual-reality-assistance-in-prostate-biopsy-under-local-anesthesia-57431https://curecurrent.com/trials/detection-of-isup-2-prostate-cancers-using-multiparametric-mri-prospective-multicenter-comparison-of-the-pi-rads-score-a-57432https://curecurrent.com/trials/focal-therapy-for-localized-prostate-cancer-57433https://curecurrent.com/trials/adjuvant-high-intensity-interval-training-during-chemotherapy-in-metastatic-prostate-cancer-patients-57434https://curecurrent.com/trials/ultrasound-guided-inguinal-indocyanine-green-injection-to-identify-and-pre-emptively-seal-lymphatic-leaks-57435https://curecurrent.com/trials/exploiting-risk-based-risk-stratification-in-early-prostate-cancer-to-discriminate-progressors-from-non-progressors-57436https://curecurrent.com/trials/prostate-accurately-targeted-radiotherapy-investigation-of-overall-treatment-time-57437https://curecurrent.com/trials/prostate-cancer-active-surveillance-trigger-trial-pcastt-uk-comparing-current-practice-for-men-with-prostate-cancer-on-a-57438https://curecurrent.com/trials/video-analysis-of-errors-and-technical-performance-within-minimally-invasive-surgery-short-title-video-analysis-in-minim-57439https://curecurrent.com/trials/retrospective-analysis-of-68ga-psma-pet-in-patients-with-prostate-cancer-experience-from-brazil-57440https://curecurrent.com/trials/study-of-high-dose-rate-hdr-monotherapy-for-low-and-intermediate-risk-prostate-cancer-57441https://curecurrent.com/trials/transdermal-estradiol-and-exercise-in-mitigating-adverse-effects-of-androgen-deprivation-therapy-for-prostate-cancer-rad-57442https://curecurrent.com/trials/combination-of-bipolar-androgen-therapy-and-nivolumab-57443https://curecurrent.com/trials/effectiveness-of-focal-therapy-in-men-with-prostate-cancer-57444https://curecurrent.com/trials/radiation-and-adebrelimab-in-prostate-cancer-with-imaging-measurable-disease-rapid-57445https://curecurrent.com/trials/mri-guided-radiotherapy-and-radiobiological-data-the-israr-database-irm-sequences-for-radiobiological-adaptative-radioth-57446https://curecurrent.com/trials/neoadjuvant-radiohormonal-therapy-for-oligometastatic-prostate-cancer-57447https://curecurrent.com/trials/exercise-for-advanced-prostate-cancer-a-multicomponent-feasibility-trial-57448https://curecurrent.com/trials/18f-dcfpyl-positron-emission-tomography-pet-in-intermediate-or-high-risk-prostate-cancer-57449https://curecurrent.com/trials/68ga-psma-in-preprostatectomy-patients-57450https://curecurrent.com/trials/neoadjuvant-psma-rlt-in-oligometastatic-pca-57451https://curecurrent.com/trials/study-of-hpn424-in-patients-with-advanced-prostate-cancer-57452https://curecurrent.com/trials/evaluation-of-the-dose-received-by-the-prostate-with-in-vivo-dosimetry-in-patients-treated-with-daily-igrt-associated-wi-57453https://curecurrent.com/trials/sex-mismatched-allogeneic-bone-marrow-transplantation-for-men-with-metastatic-castration-resistant-prostate-cancer-57454https://curecurrent.com/trials/psma-rlt-in-biochemically-recurrent-pca-57455https://curecurrent.com/trials/evaluation-of-the-efficacy-and-the-safety-of-a-stereotaxic-prostatic-radiotherapy-delivered-with-linac-mri-in-patients-w-57456https://curecurrent.com/trials/177lu-dota-tlx591-safety-biodistribution-and-dosimetry-study-57457https://curecurrent.com/trials/radical-prostatectomy-without-prostate-biopsy-following-psma-pet-ct-based-on-diagnostic-model-57458https://curecurrent.com/trials/the-safety-and-tolerability-of-gt0918-in-subjects-with-mhspc-and-mcrpc-57459https://curecurrent.com/trials/a-study-called-awareness-using-data-from-men-in-alberta-to-observe-treatment-patterns-for-metastatic-castration-sensitiv-57460https://curecurrent.com/trials/focal-therapy-for-localized-prostate-cancer-57461https://curecurrent.com/trials/ga-68-prostate-specific-membrane-antigen-pet-ct-in-gliomas-57462https://curecurrent.com/trials/treatment-satisfaction-with-ra-223-in-japan-57463https://curecurrent.com/trials/clinical-application-of-near-infrared-whole-body-heat-shock-multimodal-technique-in-treatment-of-castration-resistant-pr-57464https://curecurrent.com/trials/safety-and-tolerability-study-using-wst11-in-patients-with-localized-prostate-cancer-57465https://curecurrent.com/trials/prostate-cancer-intensive-non-cross-reactive-therapy-print-for-castration-resistant-prostate-cancer-crpc-57466https://curecurrent.com/trials/radiotherapy-combined-with-a-lhrh-ant-agonist-versus-apalutamide-in-patients-with-biochemical-recurrence-after-rp-57467https://curecurrent.com/trials/nivolumab-with-or-without-ipilimumab-in-advanced-metastatic-cancer-57468https://curecurrent.com/trials/safety-and-efficacy-of-18f-psma-1007-injection-in-suspected-persistent-or-recurrent-prostate-cancer-57469https://curecurrent.com/trials/super-fast-3t-prostate-mri-using-high-gradient-strength-and-deep-learning-57470https://curecurrent.com/trials/pragma-prostate-radio-ablation-guided-by-magnetic-resonance-imaging-acquisition-in-metastatic-prostate-cancer-57471https://curecurrent.com/trials/efficacy-evaluation-of-veru-111-for-mcrpc-in-patients-who-have-failed-at-least-one-androgen-receptor-targeting-agent-57472https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-and-pharmacokinetics-of-sol-804-in-healthy-male-subjects-57473https://curecurrent.com/trials/circulating-tumor-cells-and-mpmri-for-non-invasive-diagnosis-of-prostate-cancer-cmndpc-57474https://curecurrent.com/trials/focal-us-guided-cryo-ablation-using-dynacad-uronav-preplanning-guidance-of-intermediate-risk-prostate-cancer-57475https://curecurrent.com/trials/mr-trus-fusion-guided-prostate-biopsy-an-improved-way-to-detect-and-quantify-prostate-cancer-57476https://curecurrent.com/trials/observation-study-to-evaluate-the-efficacy-and-safety-of-ifosfamide-mesna-in-patients-with-metastatic-castration-resista-57477https://curecurrent.com/trials/a-phase-1-study-of-for46-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-57478https://curecurrent.com/trials/hdr-brachytherapy-68-ga-rm2-pet-68-ga-psma-11-pet-multi-parametric-mri-in-prostate-cancer-57479https://curecurrent.com/trials/docetaxel-radiation-therapy-and-hormone-therapy-in-treating-patients-with-locally-advanced-prostate-cancer-57480https://curecurrent.com/trials/conducting-active-surveillance-without-prostate-biopsy-for-patients-with-low-risk-suspected-prostate-cancer-57481https://curecurrent.com/trials/anti-androgens-and-cabazitaxel-in-defining-complete-response-in-prostatectomy-acdc-trial-57482https://curecurrent.com/trials/68-ga-psma-11-pet-mri-and-68-ga-rm2-pet-mri-for-evaluation-of-prostate-cancer-response-to-hifu-therapy-57483https://curecurrent.com/trials/self-administered-nitrous-oxide-sano-during-transrectal-prostate-biopsy-to-reduce-patient-anxiety-and-pain-57484https://curecurrent.com/trials/gallium-ga-68-dota-neobomb1-and-gallium-ga-68-psma-r2-pet-mri-in-diagnosing-participants-with-recurrent-prostate-cancer-57485https://curecurrent.com/trials/prevention-of-metabolic-syndrome-and-increased-weight-using-metformin-concurrent-to-androgen-deprivation-therapy-and-rad-57486https://curecurrent.com/trials/participating-in-tai-chi-to-reduce-anxiety-and-keep-up-physical-function-57487https://curecurrent.com/trials/kinesiophobia-in-prostate-cancer-57488https://curecurrent.com/trials/a-study-of-ac176-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-57489https://curecurrent.com/trials/a-study-to-evaluate-the-human-biodistribution-and-dosimetry-of-the-radionuclide-labeled-zt-111-in-patients-with-metastat-57490https://curecurrent.com/trials/68ga-psma-pet-in-the-prostate-cancer-57491https://curecurrent.com/trials/al18f-psma137-pet-ct-imaging-for-psma-positive-cancer-patients-57492https://curecurrent.com/trials/the-metformin-active-surveillance-trial-mast-study-57493https://curecurrent.com/trials/safety-and-efficacy-of-tt-00420-tablets-combined-with-toripalimab-injection-in-advanced-urological-tumors-57494https://curecurrent.com/trials/radium-223-combined-with-dexamethasone-as-first-line-therapy-in-patients-with-m-crpc-57495https://curecurrent.com/trials/determination-of-the-diagnostic-detection-rate-of-axumin-fluciclovine-digital-pet-ct-post-prostatectomy-57496https://curecurrent.com/trials/a-novel-augmented-reality-system-arssist-for-the-assistant-surgeon-in-robotic-assisted-surgery-57497https://curecurrent.com/trials/retrospective-study-to-assess-real-life-use-of-the-long-acting-gnrh-agonist-as-prostate-cancer-treatment-57498https://curecurrent.com/trials/99mtc-mip-1404-spect-ct-in-primary-staging-of-prostate-cancer-57499https://curecurrent.com/trials/prostate-advances-in-comparative-evidence-57500https://curecurrent.com/trials/genetic-counseling-processes-and-outcomes-among-males-with-prostate-cancer-progen-57501https://curecurrent.com/trials/a-prospective-pilot-study-for-the-evaluation-of-18f-fluciclovine-pet-mri-in-radio-recurrent-prostate-cancer-rrpc-pet-mri-57502https://curecurrent.com/trials/clonal-emergence-and-regression-during-radium-223-therapy-for-metastatic-prostate-cancer-57503https://curecurrent.com/trials/imu-935-in-patients-with-progressive-metastatic-castration-resistant-prostate-cancer-57504https://curecurrent.com/trials/streamlined-genetic-testing-in-prostate-cancer-57505https://curecurrent.com/trials/precise-a-study-to-gather-more-information-about-bone-fractures-and-survival-in-castration-resistant-prostate-cancer-crp-57506https://curecurrent.com/trials/tavt-45-abiraterone-acetate-granules-in-patients-with-prostate-cancer-57507https://curecurrent.com/trials/18f-flor-fc303-pet-ct-imaging-in-patients-with-prostate-cancer-57508https://curecurrent.com/trials/investigation-of-protein-biomarkers-of-prostate-cancer-57509https://curecurrent.com/trials/gtn-therapy-on-biomarkers-of-immune-escape-in-men-with-biochemical-recurrence-of-prostate-cancer-after-primary-therapy-57510https://curecurrent.com/trials/identification-of-risk-allels-for-prostate-cancer-57511https://curecurrent.com/trials/effect-of-irradiation-doses-10-gy-and-of-irradiated-bone-volume-on-the-variation-of-blood-elements-of-the-complete-blood-57512https://curecurrent.com/trials/68ga-psma-11-pet-mri-and-68ga-rm2-pet-mri-for-biopsy-guidance-in-patients-with-suspected-prostate-cancer-57513https://curecurrent.com/trials/radiotherapy-for-prostate-and-oligo-metastatic-lesions-in-patients-with-low-burden-oligo-metastatic-prostate-cancer-57514https://curecurrent.com/trials/transperineal-laser-ablation-for-low-and-intermediate-risk-prostate-cancer-a-single-cohort-analysis-57515https://curecurrent.com/trials/psma-response-in-metastasized-hormone-sensitive-prostate-cancer-enzalutamide-57516https://curecurrent.com/trials/psma-response-in-metastasized-hormone-sensitive-prostate-cancer-57517https://curecurrent.com/trials/effect-of-low-dose-500-mg-abiraterone-acetate-in-treatment-of-metastatic-prostate-cancer-patients-57518https://curecurrent.com/trials/patient-preference-of-apalutamide-versus-enzalutamide-in-patients-with-recurrent-or-metastatic-hormone-sensitive-prostat-57519https://curecurrent.com/trials/light-psma-cart-in-treating-patients-with-castrate-resistant-prostate-cancer-57520https://curecurrent.com/trials/dose-escalation-for-intraprostatic-lesions-57521https://curecurrent.com/trials/enhanced-recovery-program-after-a-robotic-assisted-surgery-raac-of-radical-prostatectomy-prosta-raac-57522https://curecurrent.com/trials/to-investigate-the-role-of-gut-microbiome-in-adt-related-metabolic-changes-in-prostate-cancer-patients-57523https://curecurrent.com/trials/ablative-radiotherapy-for-unfavorable-prostate-tumors-57524https://curecurrent.com/trials/study-to-evaluate-efficacy-and-safety-of-histrelin-subdermal-implant-in-men-with-advanced-prostate-cancer-57525https://curecurrent.com/trials/prothrombin-complex-concentrate-vs-fresh-frozen-plasma-in-goal-directed-bleeding-management-in-non-cardiac-surgery-57526https://curecurrent.com/trials/study-of-histrelin-subdermal-implant-in-patients-with-prostate-cancer-57527https://curecurrent.com/trials/analyzing-clinical-trial-experiences-of-prostate-cancer-patients-57528https://curecurrent.com/trials/vantas-implant-retrieval-study-57529https://curecurrent.com/trials/hyperthermia-enhanced-re-irradiation-of-loco-regional-recurrent-tumors-57530https://curecurrent.com/trials/intermittent-darolutamide-treatment-in-the-triple-therapy-of-mhspc-57531https://curecurrent.com/trials/prostate-cancer-detection-using-the-stockholm3-test-and-mr-fusion-biopsies-57532https://curecurrent.com/trials/detection-of-prostate-cancer-with-non-invasive-method-based-on-dna-methylation-of-circulated-tumor-dna-pbmc-57533https://curecurrent.com/trials/a-phase-i-ii-trial-of-2-deoxyglucose-2dg-for-the-treatment-of-advanced-cancer-and-hormone-refractory-prostate-cancer-57534https://curecurrent.com/trials/short-course-radiotherapy-for-localized-prostate-cancer-57535https://curecurrent.com/trials/licorice-root-extract-and-docetaxel-in-treating-patients-with-metastatic-prostate-cancer-that-did-not-respond-to-hormone-57536https://curecurrent.com/trials/atr-inhibitor-elimusertib-bay1895344-plus-niraparib-phase-1b-study-in-advanced-solid-tumors-and-ovarian-cancer-57537https://curecurrent.com/trials/pre-operative-education-modalities-to-decrease-opioid-use-57538https://curecurrent.com/trials/local-treatment-with-rp-for-newly-diagnosed-mpca-57539https://curecurrent.com/trials/digital-pet-ct-using-ga-68-psma-for-characterization-of-prostate-lesions-57540https://curecurrent.com/trials/a-parallel-arm-phase-1b-2a-study-of-dkn-01-as-monotherapy-or-in-combination-with-docetaxel-for-the-treatment-of-advanced-57541https://curecurrent.com/trials/study-of-oric-101-in-combination-with-enzalutamide-57542https://curecurrent.com/trials/evolution-177lu-psma-therapy-versus-177lu-psma-in-combination-with-ipilimumab-and-nivolumab-for-men-with-mcrpc-57543https://curecurrent.com/trials/radiation-treatment-of-lymph-node-recurrence-from-prostate-cancer-is-11c-choline-pet-ct-predictive-of-survival-outcomes-57544https://curecurrent.com/trials/development-of-artificial-intelligence-models-for-segmentation-and-characterization-of-prostate-cancer-a-single-center-r-57545https://curecurrent.com/trials/ultrasound-spectroscopy-as-early-indicators-of-radiation-treatment-response-in-prostate-rectum-and-head-neck-cancers-57546https://curecurrent.com/trials/assessment-of-predictive-role-of-11c-choline-pet-ct-on-survival-in-prostate-cancer-patients-with-biochemical-failure-wit-57547https://curecurrent.com/trials/long-term-better-than-short-term-adt-with-salvage-rt-57548https://curecurrent.com/trials/predictive-role-of-11c-choline-pet-ct-on-survival-in-prostate-cancer-patients-with-biochemical-failure-57549https://curecurrent.com/trials/exploratory-pk-and-imaging-study-of-psma-targeted-trillium-compounds-and-pti-122-in-metastatic-prostate-cancer-57550https://curecurrent.com/trials/micro-rna-expression-profiles-in-localised-prostate-cancer-57551https://curecurrent.com/trials/validation-of-the-stockholm3-test-for-detection-of-prostate-cancer-in-the-swiss-population-57552https://curecurrent.com/trials/a-phase-ii-neoadjuvant-study-of-darolutamide-plus-adt-in-men-with-localized-prostate-cancer-57553https://curecurrent.com/trials/monocentric-observational-study-on-the-diagnostic-and-prognostic-role-of-18f-psma-pet-pet-ct-and-pet-mr-in-prostate-canc-57554https://curecurrent.com/trials/68ga-rm2-pet-ct-in-detecting-regional-nodal-and-distant-metastases-in-patients-with-intermediate-or-high-risk-prostate-c-57555https://curecurrent.com/trials/pidnarulex-and-talazoparib-in-patients-with-metastatic-castration-resistant-prostate-cancer-57556https://curecurrent.com/trials/a-study-to-determine-frequency-of-dna-repair-defects-in-men-with-metastatic-prostate-cancer-57557https://curecurrent.com/trials/fear-of-cancer-recurrence-in-genitourinary-cancer-57558https://curecurrent.com/trials/fluzoparib-and-abiraterone-in-the-presurgery-treatment-of-prostate-cancer-fast-trial-57559https://curecurrent.com/trials/a-clinical-study-evaluating-the-relative-bioavailability-of-shr7280-dry-suspension-and-tablets-57560https://curecurrent.com/trials/metastasis-directed-therapy-in-castration-refractory-prostate-cancer-57561https://curecurrent.com/trials/new-markers-for-treatment-response-to-radiotherapy-in-prostate-cancer-57562https://curecurrent.com/trials/pet-imaging-in-mci-following-adt-for-pca-57563https://curecurrent.com/trials/salvage-prostatectomy-after-radiotherapy-57564https://curecurrent.com/trials/evaluation-of-the-predictive-role-of-choline-pet-ct-on-the-survival-of-patients-affected-by-prostate-cancer-57565https://curecurrent.com/trials/intensity-modulated-radiation-therapy-imrt-pelvic-nodes-prostate-57566https://curecurrent.com/trials/the-procaris-study-prostate-cancer-risk-assessment-in-general-practice-57567https://curecurrent.com/trials/archive-prostate-observational-study-of-patients-who-underwent-radical-prostatectomy-surgery-57568https://curecurrent.com/trials/urinary-and-prostate-microbiotes-and-prostate-cancer-57569https://curecurrent.com/trials/hypofractionated-focal-lesion-ablative-microboost-in-prostate-cancer-2-0-57570https://curecurrent.com/trials/day-case-endourology-patient-experience-57571https://curecurrent.com/trials/dose-finding-trial-with-a-new-treatment-degarelix-for-prostate-cancer-57572https://curecurrent.com/trials/investigation-of-a-new-trial-drug-fe200486-in-prostate-cancer-patients-57573https://curecurrent.com/trials/laparoscopic-vs-robotic-assisted-radical-prostatectomy-57574https://curecurrent.com/trials/a-randomized-study-of-testosterone-replacement-in-patients-with-low-risk-hormone-refractory-prostate-cancer-57575https://curecurrent.com/trials/pd-1-silent-psma-psca-targeted-car-t-for-the-treatment-of-prostate-cancer-57576https://curecurrent.com/trials/enzalutamide-and-indomethacin-in-treating-patients-with-recurrent-or-metastatic-hormone-resistant-prostate-cancer-57577https://curecurrent.com/trials/immunotherapy-for-men-with-objective-disease-progression-on-protocol-d9902-part-b-nct00065442-57578https://curecurrent.com/trials/androgen-suppression-with-stereotactic-body-or-external-beam-radiation-therapy-assert-57579https://curecurrent.com/trials/danish-prostate-cancer-consortium-study-1-57580https://curecurrent.com/trials/prostate-cancer-patient-management-with-18f-dcfpyl-pet-ct-57581https://curecurrent.com/trials/68ga-psma-pet-ct-in-prostate-cancer-57582https://curecurrent.com/trials/cohort-trial-in-clinical-pelivc-lymph-node-metastatic-prostate-cancer-57583https://curecurrent.com/trials/radiation-therapy-docetaxel-and-hormone-therapy-in-high-risk-locally-advanced-metastasized-prostate-cancer-57584https://curecurrent.com/trials/radiotherapy-and-androgen-deprivation-in-combination-after-local-surgery-radicals-translational-study-57585https://curecurrent.com/trials/3d-versus-robot-assisted-laparoscopic-prostatectomy-57586https://curecurrent.com/trials/effects-of-a-genistein-concentrated-polysaccharide-gcp-for-prostate-cancer-on-active-surveillance-57587https://curecurrent.com/trials/single-center-registration-study-on-her2-expression-and-clinical-pathological-characteristics-in-prostate-cancer-57588https://curecurrent.com/trials/technology-based-psychosocial-intervention-for-symptom-management-and-hrqol-in-men-living-with-advanced-prostate-cancer-57589https://curecurrent.com/trials/phase-i-ii-study-of-hydroxychloroquine-with-itraconazole-with-biochemically-recurrent-prostate-cancer-57590https://curecurrent.com/trials/soy-isoflavones-in-treating-patients-with-recurrent-prostate-cancer-or-rising-prostate-specific-antigen-57591https://curecurrent.com/trials/study-of-cb307-in-patients-with-advanced-and-or-metastatic-psma-positive-tumours-57592https://curecurrent.com/trials/a-phase-i-study-of-sor-c13-in-patients-with-advanced-solid-tumors-57593https://curecurrent.com/trials/evaluation-of-the-concordance-between-pre-therapy-dosimetry-performed-from-68ga-psma-11-dynamic-pet-and-post-treatment-d-57594https://curecurrent.com/trials/health-status-quality-of-life-and-function-in-survivors-after-radical-treatment-for-prostate-cancer-part-i-and-iia-57595https://curecurrent.com/trials/rezvilutamide-plus-abiraterone-for-metastatic-hormone-sensitive-prostate-cancer-57596https://curecurrent.com/trials/binaural-sound-for-remimazolam-induction-57597https://curecurrent.com/trials/artificial-intelligence-and-radiologists-at-prostate-cancer-detection-in-mri-the-pi-cai-challenge-57598https://curecurrent.com/trials/short-versus-long-term-androgen-deprivation-therapy-with-salvage-radiotherapy-in-prostate-cancer-uroncor-0624-57599https://curecurrent.com/trials/clinical-utility-of-myprostatescore-2-0-p2-57600https://curecurrent.com/trials/tissue-predictors-of-abiraterone-benefit-57601https://curecurrent.com/trials/ph-ii-study-to-evaluate-olaparib-with-abiraterone-in-treating-metastatic-castration-resistant-prostate-cancer-57602https://curecurrent.com/trials/neoadjuvant-androgen-deprivation-darolutamide-and-ipatasertib-in-men-with-localized-high-risk-prostate-cancer-57603https://curecurrent.com/trials/investigation-of-urinary-biomarkers-for-the-detection-of-prostate-cancer-57604https://curecurrent.com/trials/68ga-psma-11-pet-in-patients-with-prostate-cancer-57605https://curecurrent.com/trials/radicals-radiotherapy-and-androgen-deprivation-in-combination-after-local-surgery-57606https://curecurrent.com/trials/relugolix-in-combination-with-radiation-therapy-for-treating-patients-with-high-risk-prostate-cancer-57607https://curecurrent.com/trials/a-jnj-56021927-arn-509-apalutamide-qt-qtc-study-57608https://curecurrent.com/trials/the-efficacy-and-safety-of-fe-200486-in-treatment-of-patients-suffering-from-prostate-cancer-57609https://curecurrent.com/trials/effectiveness-and-safety-of-firmagon-57610https://curecurrent.com/trials/docetaxel-with-rapid-hormonal-cycling-as-a-treatment-for-patients-with-prostate-cancer-57611https://curecurrent.com/trials/aromatherapy-on-pain-and-anxiety-of-the-patients-undergoing-prostate-biopsy-57612https://curecurrent.com/trials/mdpk67b-in-patients-with-prostate-cancer-57613https://curecurrent.com/trials/acupuncture-versus-sham-acupuncture-or-usual-care-for-antiandrogen-induced-hot-flashes-in-prostate-cancer-avail-57614https://curecurrent.com/trials/optimizing-the-announcement-of-advanced-or-metastatic-prostate-cancer-using-animated-videos-cartdiag-prostate-57615https://curecurrent.com/trials/improving-prostate-lesion-classification-and-development-of-a-pi-rads-3-classifier-57616https://curecurrent.com/trials/gallium-68-psma-11-pet-in-patients-with-biochemical-recurrence-57617https://curecurrent.com/trials/prostate-metabolism-cancer-risk-and-gut-microbiota-57618https://curecurrent.com/trials/to-evaluate-the-efficacy-of-tqb3823-combined-with-abiraterone-and-prednisone-in-metastatic-castration-resistant-prostate-57619https://curecurrent.com/trials/online-adaptive-radiotherapy-using-a-novel-linear-accelerator-ethos-57620https://curecurrent.com/trials/bay88-8223-dose-finding-study-in-patients-with-hrpc-57621https://curecurrent.com/trials/a-phase-1-study-to-evaluate-escalating-doses-of-a-vaccine-based-immunotherapy-regimen-for-prostate-cancer-prca-vbir-57622https://curecurrent.com/trials/the-beijing-randomized-study-of-prostate-cancer-screening-57623https://curecurrent.com/trials/assessment-of-multi-modality-quantitative-imaging-for-evaluation-of-response-of-metastatic-prostate-cancer-to-therapy-57624https://curecurrent.com/trials/docetaxel-with-or-without-thalidomide-in-treating-patients-with-metastatic-prostate-cancer-57625https://curecurrent.com/trials/first-in-man-clinical-study-to-evaluate-safety-and-tolerability-of-an-oncolytic-adenovirus-in-prostate-cancer-patients-57626https://curecurrent.com/trials/a-study-to-learn-more-about-how-radium-223-affects-the-quality-of-life-of-colombian-patients-with-prostate-cancer-that-h-57627https://curecurrent.com/trials/antiandrogen-therapy-abiraterone-acetate-and-prednisone-with-or-without-neutron-radiation-therapy-in-treating-patients-w-57628https://curecurrent.com/trials/evaluation-of-the-sentinel-pcc4-assay-for-diagnosis-prognosis-and-monitoring-of-prostate-cancer-in-puerto-rico-57629https://curecurrent.com/trials/effect-of-perioperative-intravenous-lidocaine-infusion-in-robotic-assisted-urologic-surgery-57630https://curecurrent.com/trials/dalpiciclib-isethionate-tablets-combined-with-abiraterone-acetate-tablets-i-and-prednisone-tablets-aa-p-versus-placebo-c-57631https://curecurrent.com/trials/identification-of-clinically-insignificant-or-significant-prostate-cancer-with-the-mir-scientific-sentinel-platform-57632https://curecurrent.com/trials/magnetic-resonance-imaging-and-spectroscopy-of-the-prostate-57633https://curecurrent.com/trials/evaluation-of-molecular-forms-of-psa-and-human-kallikrein-2-in-a-cohort-of-patients-with-locally-resected-prostate-cance-57634https://curecurrent.com/trials/generation-and-validation-of-predictive-models-for-localized-prostate-cancer-treated-with-external-radiotherapy-57635https://curecurrent.com/trials/evaluating-the-impact-of-evidence-based-information-about-psa-testing-on-prostate-cancer-screening-decisions-57636https://curecurrent.com/trials/image-guided-navigation-during-robotic-sentinel-node-removal-57637https://curecurrent.com/trials/acute-toxicity-after-moderate-hypo-fractionated-intensity-modulated-radiotherapy-imrt-or-prostate-cancer-57638https://curecurrent.com/trials/radiation-induced-toxicity-in-prostate-cancer-standard-follow-up-program-prostate-57639https://curecurrent.com/trials/brachytherapy-for-recurrent-prostate-cancer-57640https://curecurrent.com/trials/a-study-evaluating-the-safety-efficacy-and-pharmacokinetics-of-ipatasertib-in-combination-with-atezolizumab-and-docetaxe-57641https://curecurrent.com/trials/pentoxifylline-atorvastatin-and-vitamin-e-in-treating-patients-with-erectile-dysfunction-after-radiation-therapy-for-pro-57642https://curecurrent.com/trials/enzalutamide-with-venetoclax-in-treating-patients-with-metastatic-castration-resistant-prostate-cancer-57643https://curecurrent.com/trials/artificial-intelligence-for-prostate-cancer-treatment-planning-57644https://curecurrent.com/trials/multi-parametric-magnetic-resonance-imaging-for-prostate-cancer-patients-57645https://curecurrent.com/trials/the-impact-of-low-pressure-pneumo-in-rarp-57646https://curecurrent.com/trials/the-impact-of-low-pressure-pneumo-in-rarp-ii-57647https://curecurrent.com/trials/phase-0-1-study-of-212pb-ng001-in-mcrpc-57648https://curecurrent.com/trials/micro-ultrasound-for-the-detection-and-localization-of-prostate-cancer-tumors-in-patients-undergoing-radical-prostatecto-57649https://curecurrent.com/trials/tracer-guided-surgery-for-recurrent-prostate-cancer-57650https://curecurrent.com/trials/gtx-758-on-serum-prostate-specific-antigen-psa-in-men-with-castrate-resistant-prostate-cancer-57651https://curecurrent.com/trials/study-of-olaparib-lynparza-versus-enzalutamide-or-abiraterone-acetate-in-men-with-metastatic-castration-resistant-prosta-57652https://curecurrent.com/trials/safety-and-tolerability-study-of-isis-eif4e-rx-in-combination-with-docetaxel-and-prednisone-crpc-57653https://curecurrent.com/trials/determining-patterns-in-trial-experiences-of-recurrent-prostate-cancer-patients-57654https://curecurrent.com/trials/telomere-associated-variables-tavs-in-prostate-cancer-57655https://curecurrent.com/trials/multivalent-conjugate-vaccine-trial-for-patients-with-biochem-relapsed-prostate-cancer-57656https://curecurrent.com/trials/immunization-with-ny-eso-1-protein-combined-with-cpg-7909-in-patients-with-prostate-cancer-57657https://curecurrent.com/trials/comparison-of-diagnostic-accuracy-of-luminal-index-and-mp-mri-for-accelerated-detection-of-significant-prostate-cancer-57658https://curecurrent.com/trials/docetaxel-androgen-deprivation-and-proton-therapy-for-high-risk-prostate-cancer-57659https://curecurrent.com/trials/phase-i-clinical-study-of-hrs-9815-for-pet-ct-imaging-in-patients-with-prostate-cancer-57660https://curecurrent.com/trials/selenomethionine-and-finasteride-before-surgery-or-radiation-therapy-in-treating-patients-with-stage-i-or-stage-ii-prost-57661https://curecurrent.com/trials/masitinib-plus-docetaxel-in-metastatic-castration-resistant-prostate-cancer-57662https://curecurrent.com/trials/prostate-oligometastatic-cancer-management-driven-by-disease-biology-et-or-immunoactivity-prometeo-57663https://curecurrent.com/trials/ipilimumab-androgen-depravation-therapy-in-prostate-cancer-57664https://curecurrent.com/trials/erdafitinib-and-abiraterone-acetate-or-enzalutamide-in-treating-patients-with-double-negative-prostate-cancer-57665https://curecurrent.com/trials/enzalutamide-with-or-without-abiraterone-and-prednisone-in-treating-patients-with-castration-resistant-metastatic-prosta-57666https://curecurrent.com/trials/to-evaluate-safety-and-tolerability-of-veru-111-in-men-with-advanced-metastatic-castration-resistant-prostate-cancer-57667https://curecurrent.com/trials/sbrt-with-focal-dose-escalation-on-dil-in-localized-prostate-cancer-57668https://curecurrent.com/trials/psa-glycomics-assay-for-early-detection-of-prostate-cancer-57669https://curecurrent.com/trials/robotic-hemi-prostatectomy-with-urethral-preservation-in-low-and-intermediate-risk-monolateral-prostate-cancer-57670https://curecurrent.com/trials/enzalutamide-with-or-without-vaccine-therapy-for-advanced-prostate-cancer-57671https://curecurrent.com/trials/copper-64-sar-bombesin-in-psma-negative-prostate-cancer-bop-57672https://curecurrent.com/trials/clinical-study-on-68ga-psma-33-for-pet-ct-imaging-of-prostate-cancer-57673https://curecurrent.com/trials/safety-and-targeting-of-anti-hk2-antibody-in-mcrpc-57674https://curecurrent.com/trials/use-of-hydroxy-methylbutyrate-to-counteract-muscle-loss-in-men-with-prostate-cancer-on-androgen-ablation-57675https://curecurrent.com/trials/study-of-177lu-psma-0057-in-metastatic-prostate-cancer-57676https://curecurrent.com/trials/a-study-of-tazemetostat-tazverik-before-prostatectomy-in-men-with-prostate-cancer-57677https://curecurrent.com/trials/a-research-called-credit-studies-how-safe-the-study-treatment-radium-223-is-and-how-well-it-works-in-chinese-men-with-ad-57678https://curecurrent.com/trials/active-surveillance-plus-as-high-intensity-focused-ultrasound-hifu-in-patients-with-localized-prostate-cancer-57679https://curecurrent.com/trials/a-phase-1-dose-escalation-and-expansion-study-of-shr7280-in-subjects-with-hormone-sensitive-prostate-cancer-57680https://curecurrent.com/trials/study-of-18f-thretide-pet-ct-in-patients-with-prostate-cancer-57681https://curecurrent.com/trials/68ga-psma-11-pet-ct-in-patients-with-various-types-of-cancer-57682https://curecurrent.com/trials/safety-study-of-continued-enzalutamide-treatment-in-prostate-cancer-patients-57683https://curecurrent.com/trials/proton-therapy-for-low-and-intermediate-risk-prostate-cancer-57684https://curecurrent.com/trials/quality-of-life-and-supportive-care-preferences-following-radiation-therapy-in-prostate-cancer-survivors-57685https://curecurrent.com/trials/increasing-access-to-definitive-treatment-for-prostate-cancer-57686https://curecurrent.com/trials/study-of-ipatasertib-or-apitolisib-with-abiraterone-acetate-versus-abiraterone-acetate-in-participants-with-castration-r-57687https://curecurrent.com/trials/darolutamide-with-radium-223-or-placebo-and-the-effect-on-radiological-progression-free-survival-for-patients-with-mcspc-57688https://curecurrent.com/trials/lenalidomide-and-cyclophosphamide-in-treating-patients-with-previously-treated-hormone-refractory-prostate-cancer-57689https://curecurrent.com/trials/correlation-between-seminal-vesicle-size-and-duration-of-sexual-abstinence-57690https://curecurrent.com/trials/phase-ii-trial-of-transdermal-estradiol-for-hormone-refractory-prostate-cancer-57691https://curecurrent.com/trials/gefitinib-and-etoposide-in-treating-patients-with-advanced-prostate-cancer-that-did-not-respond-to-hormone-therapy-57692https://curecurrent.com/trials/a-study-of-cc-90011-and-comparators-in-participants-with-prostate-cancer-57693https://curecurrent.com/trials/clinical-use-of-68ga-psma-11-pet-ct-in-diagnosing-staging-and-restaging-prostate-cancer-57694https://curecurrent.com/trials/linear-source-registry-for-prostate-cancer-57695https://curecurrent.com/trials/risk-adapted-strategy-including-magnetic-resonance-imaging-and-prostate-specific-antigen-density-in-blood-for-biopsy-dec-57696https://curecurrent.com/trials/transperineal-versus-transrectal-prostate-biopsy-57697https://curecurrent.com/trials/18f-fmau-pet-ct-in-diagnosing-and-characterizing-prostate-cancer-57698https://curecurrent.com/trials/sport-high-risk-trial-evaluating-sabr-in-prostate-cancer-57699https://curecurrent.com/trials/retrospective-study-to-describe-the-real-world-treatment-patterns-and-associated-clinical-outcomes-in-patients-with-meta-57700https://curecurrent.com/trials/mri-in-prostate-cancer-diagnosis-with-prior-risk-assessment-57701https://curecurrent.com/trials/characterization-of-circulating-tumor-cells-ctcs-in-high-risk-and-early-metastatic-prostate-cancer-patients-using-parsor-57702https://curecurrent.com/trials/non-systemic-treatment-for-patients-with-low-volume-metastatic-prostate-cancer-57703https://curecurrent.com/trials/a-study-comparing-urolift-and-turp-ahead-of-radiotherapy-in-men-with-urinary-symptoms-secondary-to-prostate-enlargement-57704https://curecurrent.com/trials/quality-of-life-and-shared-decision-making-in-prostate-cancer-57705https://curecurrent.com/trials/impact-of-patient-s-therapeutic-education-in-apa-and-dietetic-on-radiotherapy-reproducibility-sessions-for-prostate-canc-57706https://curecurrent.com/trials/the-robot-assisted-laparoscopic-radical-prostatectomy-combined-anterior-and-posterior-approach-57707https://curecurrent.com/trials/3tmpo-triple-tracer-strategy-against-metastatic-prostate-cancer-57708https://curecurrent.com/trials/68-ga-psma-for-high-risk-prostate-cancer-57709https://curecurrent.com/trials/actinium-j591-radionuclide-therapy-in-psma-detected-metastatic-hormone-sensitive-recurrent-prostate-cancer-57710https://curecurrent.com/trials/a-journey-into-participation-patterns-among-metastatic-prostate-cancer-patients-57711https://curecurrent.com/trials/observation-or-radical-treatment-in-patients-with-prostate-cancer-57712https://curecurrent.com/trials/phase-1-2-clinical-study-of-hrs-4357-in-patients-with-advanced-prostate-cancer-57713https://curecurrent.com/trials/effect-of-dutasteride-on-androgen-response-gene-expression-in-patients-with-advanced-prostate-cancer-57714https://curecurrent.com/trials/a-phase-ii-study-of-px-866-in-patients-with-recurrent-or-metastatic-castration-resistant-prostate-cancer-57715https://curecurrent.com/trials/soccer-intervention-in-prostate-cancer-survivors-57716https://curecurrent.com/trials/a-study-of-cart-psma-tgf-rdn-in-patients-with-metastatic-castration-resistant-prostate-cancer-57717https://curecurrent.com/trials/artificial-intelligence-based-computer-aided-diagnosis-of-prostate-cancer-57718https://curecurrent.com/trials/prostate-medication-metabolism-and-gut-microbiota-57719https://curecurrent.com/trials/radiation-therapy-with-androgen-suppression-in-treating-patients-with-prostate-cancer-57720https://curecurrent.com/trials/a-study-of-tmpsma-02-chimeric-antigen-receptor-car-t-cells-in-patients-with-metastatic-castration-resistant-prostate-can-57721https://curecurrent.com/trials/inter-observer-variability-in-the-segmentation-of-prostate-tumour-lesions-using-multiparametric-mri-variop-57722https://curecurrent.com/trials/sacral-nerve-stimulation-in-treating-low-anterior-resection-syndrome-or-fecal-incontinence-in-patients-with-locally-adva-57723https://curecurrent.com/trials/atorvastatin-calcium-in-preventing-metabolic-syndrome-in-prostate-cancer-patients-receiving-androgen-deprivation-therapy-57724https://curecurrent.com/trials/docetaxel-and-hydroxychloroquine-in-treating-patients-with-metastatic-prostate-cancer-57725https://curecurrent.com/trials/a-study-of-azd4635-with-durvalumab-and-with-cabazitaxel-and-durvalumab-in-patients-with-mcrpc-57726https://curecurrent.com/trials/the-effect-of-the-educat-on-and-counsel-ng-of-prostatectomy-pat-ents-57727https://curecurrent.com/trials/a-study-of-ft-7051-in-men-with-mcrpc-57728https://curecurrent.com/trials/comparing-the-efficacy-and-safety-of-rezvilutamide-adt-docetaxel-versus-rezvilutamide-adt-in-the-mhspc-57729https://curecurrent.com/trials/improvement-of-rarp-outcomes-via-3d-printed-virtual-prostate-models-57730https://curecurrent.com/trials/a-phase-2-trial-of-darolutamide-as-a-prostate-specific-membrane-antigen-psma-expression-enhancer-in-patients-with-locali-57731https://curecurrent.com/trials/docetaxel-and-prednisone-with-out-ogx-011-in-recurrent-or-metastatic-prostate-cancer-that-did-not-respond-to-previous-ho-57732https://curecurrent.com/trials/study-to-compare-the-effects-of-drug-darolutamide-and-drug-enzalutamide-on-physical-function-including-balance-and-daily-57733https://curecurrent.com/trials/sorafenib-in-treating-patients-with-metastatic-or-recurrent-prostate-cancer-57734https://curecurrent.com/trials/sb939-in-treating-patients-with-recurrent-or-metastatic-prostate-cancer-57735https://curecurrent.com/trials/androgen-suppression-and-radiation-with-out-docetaxel-in-high-risk-localized-prostate-cancer-57736https://curecurrent.com/trials/reolysin-combined-with-docetaxel-and-prednisone-or-docetaxel-and-prednisone-alone-in-metastatic-castration-resistant-pro-57737https://curecurrent.com/trials/hormone-therapy-and-ogx-011-before-radical-prostatectomy-in-treating-patients-with-prostate-cancer-57738https://curecurrent.com/trials/effect-of-ehealth-coaching-program-on-patient-reported-outcomes-of-men-with-prostate-cancer-57739https://curecurrent.com/trials/the-role-of-68ga-psma-11-pet-prostate-specific-membrane-antigen-in-surgery-guidance-in-prostate-cancer-57740https://curecurrent.com/trials/trial-of-qlh12016-in-patients-with-metastatic-castration-resistant-prostate-cancer-57741https://curecurrent.com/trials/robot-assisted-urological-surgeries-using-the-microhand-s-robot-57742https://curecurrent.com/trials/facbc-outcomes-for-post-prostatectomy-57743https://curecurrent.com/trials/decision-aids-to-improve-knowledge-in-patients-with-prostate-cancer-57744https://curecurrent.com/trials/vaccine-therapy-and-pembrolizumab-in-treating-patients-with-hormone-resistant-metastatic-prostate-cancer-57745https://curecurrent.com/trials/study-of-focal-ablation-of-the-prostate-with-nanotherm-therapy-system-for-intermediate-risk-prostate-cancer-57746https://curecurrent.com/trials/androgen-deprivation-therapy-and-cardiovascular-risk-a-nationwide-population-based-cohort-study-57747https://curecurrent.com/trials/leuprolide-acetate-3-75-mg-depot-injection-for-patients-with-advanced-prostate-cancer-57748https://curecurrent.com/trials/br55-in-prostate-cancer-an-exploratory-clinical-trial-57749https://curecurrent.com/trials/anticoagulant-antiaggregant-use-and-postoperative-bleeding-risk-in-patients-with-bladder-tumor-and-benign-prostatic-hype-57750https://curecurrent.com/trials/prince-psma-lutetium-radionuclide-therapy-and-immunotherapy-in-prostate-cancer-57751https://curecurrent.com/trials/prediction-of-the-pronounce-prostate-cancer-trial-in-healthcare-claims-data-57752https://curecurrent.com/trials/nerve-sparing-robot-assisted-radical-prostatectomy-using-a-personalized-3d-printed-prostate-model-for-selective-resectio-57753https://curecurrent.com/trials/total-body-pet-ct-imaging-of-prostate-cancer-using-illuccix-57754https://curecurrent.com/trials/a-study-of-participants-with-advanced-prostate-cancer-in-canada-57755https://curecurrent.com/trials/use-of-indocyanine-green-in-robotic-prostate-surgeries-57756https://curecurrent.com/trials/luteinizing-hormone-releasing-hormone-agonist-therapy-and-iodine-i-125-implant-in-treating-patients-with-previously-untr-57757https://curecurrent.com/trials/lidocaine-combined-with-sufentanil-for-preventing-catheter-related-bladder-discomfort-57758https://curecurrent.com/trials/comparing-a-6-month-vs-long-term-course-of-rezvilutamide-with-adt-plus-chemotherapy-in-mhspc-57759https://curecurrent.com/trials/head-to-head-comparison-of-68ga-ga-psma-d5-with-68ga-ga-psma-11-pet-ct-in-pca-diagnosis-recurrence-and-metastasis-57760https://curecurrent.com/trials/clinical-study-on-the-efficacy-and-safety-of-rc48-adc-in-the-treatment-of-metastatic-castration-resistant-prostate-cance-57761https://curecurrent.com/trials/prostvac-psa-tricom-in-preventing-disease-progression-in-patients-with-localized-prostate-cancer-undergoing-active-surve-57762https://curecurrent.com/trials/evaluation-of-safety-and-efficacy-of-kpg-121-plus-enzalutamide-abiraterone-or-apalutamide-in-crpc-patients-57763https://curecurrent.com/trials/pd1-integrated-anti-psma-cart-in-treating-patients-with-castrate-resistant-prostate-cancer-57764https://curecurrent.com/trials/a-multi-centre-prospective-observational-study-on-effectiveness-and-safety-of-zoladex-goserelin-acetate-implant-10-8-mg-57765https://curecurrent.com/trials/esk981-in-treating-patients-with-metastatic-castrate-resistant-prostate-cancer-57766https://curecurrent.com/trials/the-efficacy-and-safety-of-chinese-domestic-surgical-robot-system-in-urological-telesurgery-57767https://curecurrent.com/trials/the-effect-of-frailty-on-blood-biology-indicators-quality-of-life-and-survival-of-patients-with-radical-prostatectomy-57768https://curecurrent.com/trials/neratinib-in-patients-with-metastatic-castration-resistant-prostate-cancer-57769https://curecurrent.com/trials/polaprezinc-treatment-for-enzalutamide-or-abiraterone-resistant-crpc-57770https://curecurrent.com/trials/biodfence-g3-for-full-nerve-sparing-robotic-assisted-radical-prostatectomy-57771https://curecurrent.com/trials/study-of-oral-rucaparib-with-other-anticancer-agents-in-metastatic-castration-resistant-prostate-cancer-patients-ramp-57772https://curecurrent.com/trials/radioablation-with-or-without-androgen-deprivation-therapy-in-metachronous-prostate-cancer-oligometastasis-57773https://curecurrent.com/trials/short-term-high-precision-radiotherapy-for-early-prostate-cancer-with-concomitant-boost-on-the-dominant-lesion-57774https://curecurrent.com/trials/carbon-ions-boost-followed-by-pelvic-photon-radiotherapy-for-high-risk-prostate-cancer-57775https://curecurrent.com/trials/2-ablative-radiotherapy-treatments-for-prostate-cancer-57776https://curecurrent.com/trials/investigation-of-metformin-in-patients-with-castration-resistant-prostate-cancer-in-combination-with-enzalutamide-vs-enz-57777https://curecurrent.com/trials/implant-radiation-therapy-using-radioactive-iodine-in-treating-patients-with-localized-prostate-cancer-57778https://curecurrent.com/trials/insulin-resistance-and-androgen-deprivation-therapy-57779https://curecurrent.com/trials/psa-vaccine-therapy-in-treating-patients-with-advanced-prostate-cancer-57780https://curecurrent.com/trials/mobile-health-app-to-mitigate-the-metabolic-effects-of-androgen-deprivation-therapy-57781https://curecurrent.com/trials/the-effect-of-pneumoperitoneum-raised-pressure-in-the-peritoneal-cavity-during-robotic-kidney-prostate-cancer-surgery-57782https://curecurrent.com/trials/chemotherapy-with-or-without-biological-therapy-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-respon-57783https://curecurrent.com/trials/effect-of-gtx-758-on-total-and-free-testosterone-levels-in-men-with-prostate-cancer-57784https://curecurrent.com/trials/gallium-68-citrate-pet-used-in-prostate-cancer-57785https://curecurrent.com/trials/an-extension-long-term-safety-and-tolerability-trial-of-degarelix-in-chinese-patients-with-prostate-cancer-57786https://curecurrent.com/trials/a-study-of-orally-administered-jbi-802-an-lsd1-hdac6-inhibitor-in-patients-with-advanced-solid-tumors-57787https://curecurrent.com/trials/paclitaxel-plus-estramustine-in-treating-patients-with-metastatic-prostate-cancer-57788https://curecurrent.com/trials/epoetin-alfa-with-or-without-dexamethasone-in-treating-fatigue-and-anemia-in-patients-with-hormone-refractory-prostate-c-57789https://curecurrent.com/trials/hormone-therapy-compared-with-combination-chemotherapy-in-treating-patients-with-prostate-cancer-57790https://curecurrent.com/trials/pet-mri-in-patients-with-suspected-prostate-cancer-57791https://curecurrent.com/trials/68ga-psma-11-pet-for-the-diagnosis-of-biochemically-recurrent-prostate-cancer-57792https://curecurrent.com/trials/mind-body-health-in-uro-oncology-research-study-57793https://curecurrent.com/trials/actium-225-prostate-specific-membrane-antigen-imaging-therapy-57794https://curecurrent.com/trials/shr7390-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-57795https://curecurrent.com/trials/clinical-utility-study-for-myprostatescore-57796https://curecurrent.com/trials/pioneering-advances-in-care-and-education-pace-57797https://curecurrent.com/trials/prostate-cancer-prevention-study-for-men-with-high-grade-pin-prostatic-intraepithelial-neoplasia-57798https://curecurrent.com/trials/a-study-of-rucaparib-in-patients-with-metastatic-castration-resistant-prostate-cancer-and-homologous-recombination-gene-57799https://curecurrent.com/trials/the-application-value-of-18f-prostate-specific-membrane-antigen-pet-ct-in-prostate-cancer-57800https://curecurrent.com/trials/core-stability-as-a-prognostic-factor-of-urinary-incontinence-in-patients-undergoing-robot-assisted-laparoscopic-prostat-57801https://curecurrent.com/trials/docetaxel-with-or-without-ascorbic-acid-in-treating-patients-with-metastatic-prostate-cancer-57802https://curecurrent.com/trials/efficacy-and-toxicity-of-bicalutamide-and-dutasteride-vs-standard-care-for-prostate-cytoreduction-for-brachytherapy-57803https://curecurrent.com/trials/ctc-free-dna-stem-cells-and-emt-related-antigens-as-biomarkers-of-activity-of-cabazitaxel-in-crpc-57804https://curecurrent.com/trials/evaluating-return-to-continence-and-potency-following-radical-prostatectomy-57805https://curecurrent.com/trials/factors-affecting-androgen-deprivation-therapy-choice-in-prostate-cancer-patients-57806https://curecurrent.com/trials/daily-adaptive-radiotherapy-in-postoperative-hypofractionated-salvage-radiotherapy-for-prostate-cancer-patients-57807https://curecurrent.com/trials/anxiety-before-non-cardiac-surgery-in-adults-57808https://curecurrent.com/trials/twice-high-dose-external-beam-radiotherapy-by-image-guided-tomotherapy-for-organ-confined-prostate-cancer-treatment-emul-57809https://curecurrent.com/trials/arn-509-plus-everolimus-in-men-with-progressive-metastatic-castration-resistant-prostate-cancer-after-treatment-with-abi-57810https://curecurrent.com/trials/mental-wellbeing-and-quality-of-life-in-prostate-cancer-57811https://curecurrent.com/trials/androgen-ablation-therapy-with-or-without-vaccine-therapy-in-treating-patients-with-prostate-cancer-57812https://curecurrent.com/trials/study-evaluating-the-safety-and-tolerability-of-l-377202-57813https://curecurrent.com/trials/validation-of-radioisotope-guided-lymphadenectomy-for-loco-regional-staging-in-patients-with-intermediate-or-high-risk-p-57814https://curecurrent.com/trials/transperineal-fusion-biopsy-versus-transrectal-57815https://curecurrent.com/trials/evaluation-of-a-mri-based-prostate-cancer-screening-program-57816https://curecurrent.com/trials/muscadine-plus-mpx-in-men-with-prostate-cancer-57817https://curecurrent.com/trials/cyp3a4-activity-in-patients-with-prostate-cancer-versus-male-patients-with-other-solid-tumours-57818https://curecurrent.com/trials/hypofractionated-image-guided-radiotherapy-for-prostate-cancer-the-height-trial-57819https://curecurrent.com/trials/start-met-hs-prostate-cancer-sbrt-androgen-receptor-therapy-metastatic-hspc-57820https://curecurrent.com/trials/68ga-psma-11-pet-ct-in-recurrent-prostate-cancer-57821https://curecurrent.com/trials/to-determine-an-effective-dose-of-veru-100-for-the-treatment-of-advanced-prostate-cancer-57822https://curecurrent.com/trials/an-extension-study-mri-us-fusion-imaging-and-biopsy-in-combination-with-nanoparticle-directed-focal-therapy-for-ablation-57823https://curecurrent.com/trials/phase-ii-study-of-adenovirus-psa-vaccine-in-men-with-recurrent-prostate-cancer-after-local-therapy-app21-57824https://curecurrent.com/trials/expanded-access-to-gallium-68-psma-11-pet-in-patients-with-biochemical-recurrent-prostate-cancer-57825https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-and-safety-of-ly01005-in-patients-with-prostate-cancer-compared-to-zoladex-57826https://curecurrent.com/trials/a-shr3680-qt-qtc-study-on-castration-resistant-prostate-cancer-subjects-57827https://curecurrent.com/trials/insulin-resistance-following-adt-for-prostate-ca-57828https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-and-safety-of-ly01022-in-patients-with-prostate-cancer-compared-with-zoladex-10-8mg-57829https://curecurrent.com/trials/first-in-human-study-of-ccw702-in-patients-with-metastatic-castration-resistant-prostate-cancer-57830https://curecurrent.com/trials/perception-of-cohesion-within-a-relationship-dyadic-adjustment-on-the-quality-of-life-of-patients-with-prostate-cancer-w-57831https://curecurrent.com/trials/multicenter-prospective-clinical-study-of-the-serum-raman-spectroscopy-intelligent-system-for-the-diagnosis-of-prostate-57832https://curecurrent.com/trials/mindfulness-online-for-symptom-alleviation-and-improvement-in-cancer-of-the-prostate-57833https://curecurrent.com/trials/lhrh-analogue-therapy-with-enzalutamide-or-bicalutamide-in-treating-patients-with-hormone-sensitive-prostate-cancer-57834https://curecurrent.com/trials/cyberknife-radiosurgery-for-organ-confined-prostate-cancer-homogenous-dose-distribution-57835https://curecurrent.com/trials/to-evaluate-luts-and-complications-between-indwelling-catheter-and-temporary-prostatic-stent-in-patients-undergoing-mini-57836https://curecurrent.com/trials/cyberknife-radiosurgery-for-low-intermediate-risk-prostate-cancer-emulating-hdr-brachytherapy-dosimetry-57837https://curecurrent.com/trials/cosmetic-appeal-hrqol-and-effectiveness-of-simple-and-pseudotesticular-techniques-of-orchidectomy-in-prostate-cancer-57838https://curecurrent.com/trials/focal-exablate-mr-guided-focused-ultrasound-treatment-for-management-of-organ-confined-intermediate-risk-prostate-cancer-57839https://curecurrent.com/trials/pc-360-survivorship-57840https://curecurrent.com/trials/trial-of-vaccine-therapy-with-mrna-transfected-dendritic-cells-in-patients-with-androgen-resistant-metastatic-prostate-c-57841https://curecurrent.com/trials/psma-pet-for-biopsy-and-treatment-guidance-in-primary-prostate-cancer-57842https://curecurrent.com/trials/enzalutamide-external-beam-rt-for-prostate-57843https://curecurrent.com/trials/investigating-mindfulness-and-music-to-ease-radiation-side-effects-in-prostate-cancer-57844https://curecurrent.com/trials/al18f-psma-617-and-68ga-psma-617-pet-ct-imaging-in-the-same-group-of-prostate-cancer-patients-57845https://curecurrent.com/trials/use-of-spect-ct-for-comparison-of-dosimetry-methods-in-psma-targeted-radioligand-therapy-spectacular-study-57846https://curecurrent.com/trials/prostate-immobilization-device-used-during-radiation-treatments-to-decrease-rectal-bleeding-57847https://curecurrent.com/trials/influence-of-prostate-cancer-radiation-on-aging-57848https://curecurrent.com/trials/a-phase-ii-prospective-study-of-mri-in-the-reclassification-of-men-considering-active-surveillance-in-prostate-cancer-57849https://curecurrent.com/trials/pembro-and-her2bi-armed-activated-t-cells-in-treating-patients-with-metastatic-castration-resistant-prostate-cancer-57850https://curecurrent.com/trials/trametinib-in-treating-patients-with-progressive-metastatic-hormone-resistant-prostate-cancer-57851https://curecurrent.com/trials/evaluation-of-length-and-quality-of-prostate-biopsies-taken-by-a-new-biopsy-needle-57852https://curecurrent.com/trials/phase-ii-study-of-adenovirus-psa-vaccine-in-men-with-hormone-refractory-prostate-cancer-57853https://curecurrent.com/trials/phase-1-study-of-atrs-2002-in-healthy-male-adults-57854https://curecurrent.com/trials/single-dose-versus-double-dose-tamsulosin-in-management-of-moderate-and-severe-luts-due-to-bph-57855https://curecurrent.com/trials/study-of-serum-and-urinary-biomarkers-and-radiation-cystitis-in-patients-treated-with-radiotherapy-for-localized-prostat-57856https://curecurrent.com/trials/best-systemic-therapy-or-best-systemic-therapy-bst-plus-definitive-treatment-radiation-or-surgery-57857https://curecurrent.com/trials/sipuleucel-t-with-or-without-tasquinimod-in-treating-patients-with-metastatic-hormone-resistant-prostate-cancer-57858https://curecurrent.com/trials/cognitive-fusion-prostate-biopsy-with-biparametric-magnetic-resonance-in-the-detection-of-prostate-cancer-57859https://curecurrent.com/trials/from-psa-to-stockholm3-study-part-1-57860https://curecurrent.com/trials/psma-pet-scan-and-mpmri-for-prostate-cancer-detection-57861https://curecurrent.com/trials/the-combination-of-psma-pet-mr-and-p2psa-in-early-diagnosis-of-prostate-cancer-57862https://curecurrent.com/trials/effects-of-prostate-cancer-on-brain-function-57863https://curecurrent.com/trials/feasibility-of-measuring-exercise-s-effects-on-molecular-mechanisms-of-disease-progression-in-prostate-cancer-57864https://curecurrent.com/trials/bay88-8223-does-response-study-in-hrpc-patients-57865https://curecurrent.com/trials/a-study-of-pnt2258-in-patients-with-advanced-solid-tumors-57866https://curecurrent.com/trials/deep-learning-super-resolution-reconstruction-for-fast-and-motion-robust-t2-weighted-prostate-mri-57867https://curecurrent.com/trials/a-phase-ii-study-evaluating-intravenous-melphalan-with-autologous-whole-blood-stem-cell-transplantation-over-three-cycle-57868https://curecurrent.com/trials/tranexamic-acid-s-effects-in-patients-undergoing-laparoscopic-radical-prostatectomy-57869https://curecurrent.com/trials/treatment-outcomes-in-a-non-study-population-of-symptomatic-mcrpc-patients-treated-with-radium-223-57870https://curecurrent.com/trials/srt-versus-srt-adt-in-prostate-cancer-57871https://curecurrent.com/trials/177lu-labeled-ny108-spect-imaging-in-patients-57872https://curecurrent.com/trials/systemic-therapy-in-advancing-or-metastatic-prostate-cancer-evaluation-of-drug-efficacy-57873https://curecurrent.com/trials/68ga-thp-psma-pet-ct-in-prostate-cancer-clinical-stage-and-restage-57874https://curecurrent.com/trials/hrr-prevalence-in-latam-prospect-study-57875https://curecurrent.com/trials/acupuncture-with-press-tack-needles-for-perioperative-pain-after-open-radical-prostatectomy-57876https://curecurrent.com/trials/a-vigibase-pharmacovigilance-study-of-enzalutamide-drug-induced-neurotoxicity-57877https://curecurrent.com/trials/68ga-psma-11-pet-ct-in-imaging-patients-with-intermediate-or-high-risk-prostate-cancer-before-surgery-57878https://curecurrent.com/trials/two-tracer-positron-emission-tomography-combination-for-efficacy-estimation-of-prostate-specific-membrane-antigen-radiol-57879https://curecurrent.com/trials/multiparametric-ultrasound-study-for-the-detection-of-prostate-cancer-57880https://curecurrent.com/trials/comparison-of-outcomes-of-multiple-platforms-for-assisted-robotic-prostate-57881https://curecurrent.com/trials/sbrt-vs-conventional-fractionation-with-hdr-boost-for-prostate-cancer-57882https://curecurrent.com/trials/identification-of-predictive-biomarkers-57883https://curecurrent.com/trials/suv-on-psma-pet-ct-in-non-prostate-tumors-57884https://curecurrent.com/trials/68ga-psma-11-patients-with-newly-diagnosed-and-recurrent-prostate-cancer-firefly-57885https://curecurrent.com/trials/prostate-cancer-patients-with-biochemical-recurrence-57886https://curecurrent.com/trials/68ga-rm2-pet-mri-in-biochemically-recurrent-prostate-cancer-57887https://curecurrent.com/trials/pet-mr-for-prostate-cancer-restaging-a-phase-ii-prospective-monocentric-study-57888https://curecurrent.com/trials/pharmacokinetics-of-ia-and-iv-ga68-psma-11-infusion-57889https://curecurrent.com/trials/non-randomized-trial-assessing-pain-efficacy-with-radium-223-in-symptomatic-metastatic-castration-resistant-prostate-can-57890https://curecurrent.com/trials/j591-in-patients-with-advanced-prostate-cancer-and-unfavorable-circulating-tumor-cell-counts-57891https://curecurrent.com/trials/improving-decision-making-for-low-health-literate-prostate-ca-patients-57892https://curecurrent.com/trials/phase-ii-trial-of-focal-cryotherapy-for-prostate-cancer-57893https://curecurrent.com/trials/influence-of-emt-on-ctcs-and-disease-progression-in-prostate-cancer-57894https://curecurrent.com/trials/active-surveillance-or-radical-treatment-for-newly-diagnosed-patients-with-a-localized-low-risk-prostate-cancer-start-57895https://curecurrent.com/trials/carbohydrate-restricted-diet-intervention-for-men-on-prostate-cancer-active-surveillance-57896https://curecurrent.com/trials/modifying-metabolic-syndrome-and-cardiovascular-risk-for-prostate-cancer-patients-on-adt-using-a-risk-factor-modificatio-57897https://curecurrent.com/trials/a-study-to-examine-the-effectiveness-of-aspirin-and-or-vitamin-d3-to-prevent-prostate-cancer-progression-57898https://curecurrent.com/trials/ex-vivo-investigation-of-beta-probe-for-prostate-cancer-resection-and-evaluation-of-psma-pet-for-diagnosis-of-intraprost-57899https://curecurrent.com/trials/hyperpolarized-carbon-13-imaging-of-metastatic-prostate-cancer-57900https://curecurrent.com/trials/comcancer-use-of-let-s-discuss-health-website-by-patients-with-prostate-cancer-undergoing-radiation-oncology-treatment-57901https://curecurrent.com/trials/androgen-deprivation-therapy-muscle-protein-metabolism-and-blood-glucose-57902https://curecurrent.com/trials/safety-tolerability-distribution-dose-effect-of-neoadjuvant-transarterial-chemoembolization-with-doxorubicin-in-prostate-57903https://curecurrent.com/trials/pallion-palliative-care-in-oncology-57904https://curecurrent.com/trials/docetaxel-or-hormone-therapy-as-second-line-treatment-in-patients-with-asymptomatic-or-oligosymptomatic-metastatic-castr-57905https://curecurrent.com/trials/evaluation-of-intraprostatic-fiducial-markers-for-external-beam-radiation-therapy-57906https://curecurrent.com/trials/predicting-prostate-biopsy-results-with-biomarkers-and-mpmri-57907https://curecurrent.com/trials/reimagine-prostate-cancer-risk-57908https://curecurrent.com/trials/adjutant-apalutamide-plus-adt-in-post-rp-patients-with-high-risk-of-recurrence-ares-study-57909https://curecurrent.com/trials/diet-in-altering-disease-progression-in-patients-with-prostate-cancer-on-active-surveillance-57910https://curecurrent.com/trials/diagnostic-and-prognostic-accuracy-of-fdht-pet-and-liquid-biopsies-in-prostate-cancer-57911https://curecurrent.com/trials/the-role-of-68gallium-psma-11-in-enhancing-diagnosis-of-primary-and-metastatic-prostate-cancer-57912https://curecurrent.com/trials/comparison-of-pet-imaging-patterns-with-psma-and-ar-expression-in-prostate-cancer-and-bladder-cancer-57913https://curecurrent.com/trials/correlation-of-imaging-findings-with-clinical-findings-and-patient-outcomes-in-prostate-cancer-57914https://curecurrent.com/trials/a-2-part-phase-2-trial-of-galeterone-in-the-treatment-of-castration-resistant-prostate-cancer-57915https://curecurrent.com/trials/a-study-of-galeterone-compared-to-enzalutamide-in-men-expressing-androgen-receptor-splice-variant-7-mrna-ar-v7-metastati-57916https://curecurrent.com/trials/study-of-hypofractionated-proton-beam-radiation-therapy-for-prostate-cancer-57917https://curecurrent.com/trials/comparison-study-of-pet-ct-or-pet-mri-imaging-to-magnetic-resonance-imaging-mri-alone-in-men-with-prostate-cancer-57918https://curecurrent.com/trials/intraoperative-dosimetry-for-prostate-brachytherapy-using-fluoroscopy-and-ultrasound-57919https://curecurrent.com/trials/reducing-the-effects-of-active-surveillance-stress-uncertainty-and-rumination-thru-engagement-in-mindfulness-education-57920https://curecurrent.com/trials/us-mri-fusion-local-anestesia-transperineal-prostate-biopsies-for-detection-of-prostate-cancer-57921https://curecurrent.com/trials/personalizing-docetaxel-dosing-in-advanced-prostate-cancer-57922https://curecurrent.com/trials/extended-pelvic-lymph-node-dissection-vs-no-pelvic-lymph-node-dissection-at-radical-prostatectomy-for-intermediate-and-h-57923https://curecurrent.com/trials/axitinib-before-surgery-in-treating-patients-with-high-risk-prostate-cancer-57924https://curecurrent.com/trials/rezvilutamide-in-patients-with-biochemical-recurrence-after-radical-prostatectomy-for-prostate-cancer-57925https://curecurrent.com/trials/intraoperative-nerve-monitoring-during-robotic-assisted-radical-prostatectomy-57926https://curecurrent.com/trials/srt-in-combination-with-pembrolizumab-in-patients-with-recurrent-prostate-cancer-after-radical-prostatectomy-57927https://curecurrent.com/trials/molecular-profiling-in-prostate-cancer-57928https://curecurrent.com/trials/symptom-management-education-and-telephone-follow-up-quality-of-life-57929https://curecurrent.com/trials/metabolomic-study-for-localized-prostate-cancer-57930https://curecurrent.com/trials/biomarker-study-of-in-men-with-psa-progression-on-abi-for-cr-or-cs-pc-bio-stamp-57931https://curecurrent.com/trials/ga-68-psma-11-in-men-with-prostate-cancer-57932https://curecurrent.com/trials/quality-of-life-in-patients-with-clinically-localized-prostate-cancer-treated-with-radiosurgery-57933https://curecurrent.com/trials/99mtc-p137-spect-ct-in-prostate-cancer-57934https://curecurrent.com/trials/phase-ii-study-to-evaluate-conventional-radiation-therapy-followed-by-radiosurgical-boost-in-clinically-localized-prosta-57935https://curecurrent.com/trials/the-performance-of-da-vinci-sp-system-on-extraperitoneal-approach-radical-prostatectomy-57936https://curecurrent.com/trials/cellular-effect-of-cholesterol-lowering-prior-to-prostate-removal-57937https://curecurrent.com/trials/msg-use-with-18f-dcfpyl-pet-ct-imaging-57938https://curecurrent.com/trials/a-study-of-definitive-therapy-to-treat-prostate-cancer-after-prostatectomy-57939https://curecurrent.com/trials/in-situ-clonal-heterogeneity-in-prostatic-diagnostic-biopsies-57940https://curecurrent.com/trials/a-study-of-the-value-of-hybrid-pet-mr-and-pet-ct-in-prostate-cancer-57941https://curecurrent.com/trials/hypofractionated-radiotherapy-for-prostate-cancer-57942https://curecurrent.com/trials/safety-and-efficacy-of-two-step-radical-prostatectomy-57943https://curecurrent.com/trials/the-ddi-study-had-been-designed-to-investigate-the-effect-of-shr3680-on-the-pharmacokinetics-of-midazolam-s-warfarin-and-57944https://curecurrent.com/trials/optimizing-prostate-cancer-treatment-in-men-with-advanced-local-disease-57945https://curecurrent.com/trials/apalutamide-in-treating-patients-with-prostate-cancer-who-are-in-active-surveillance-57946https://curecurrent.com/trials/surgery-with-or-without-docetaxel-and-leuprolide-or-goserelin-in-treating-patients-with-high-risk-localized-prostate-can-57947https://curecurrent.com/trials/safety-and-security-evaluation-of-patients-submitted-to-minimally-invasive-radical-prostatectomy-57948https://curecurrent.com/trials/metformin-hydrochloride-and-aspirin-in-treating-patients-with-hormone-dependent-prostate-cancer-that-has-progressed-afte-57949https://curecurrent.com/trials/physical-activity-experiment-on-male-prostate-cancer-patients-57950https://curecurrent.com/trials/apalutamiapalutamide-and-stereotactic-body-radiation-therapy-for-metastatic-prostate-cancer-57951https://curecurrent.com/trials/metastatic-prostate-cancer-men-s-attitudes-towards-treatment-of-the-local-tumour-and-metastasis-evaluative-research-57952https://curecurrent.com/trials/maximal-cytoreductive-therapies-on-post-treatment-metastases-in-pts-with-mhspc-during-apalutamide-plus-adt-treatment-57953https://curecurrent.com/trials/percutaneous-high-dose-radiotherapy-in-patients-with-oligometastases-of-prostate-carcinoma-57954https://curecurrent.com/trials/safety-and-efficacy-study-of-kx2-391-for-treatment-of-bone-metastatic-castration-resistant-prostate-cancer-57955https://curecurrent.com/trials/targeted-microwave-focal-therapy-57956https://curecurrent.com/trials/study-of-nanoknife-for-ablation-of-prostate-cancer-in-intermediate-risk-patients-57957https://curecurrent.com/trials/proton-radiation-therapy-in-treating-patients-with-prostate-cancer-57958https://curecurrent.com/trials/radiotherapy-of-the-prostate-and-the-pelvic-lymph-nodes-after-neoadjuvant-antihormonal-treatment-57959https://curecurrent.com/trials/development-of-urologic-registry-for-personalized-medicine-in-patients-with-urologic-malignant-diseases-by-analyzing-mic-57960https://curecurrent.com/trials/hypoxia-driven-prostate-cancer-genomics-hyprogen-57961https://curecurrent.com/trials/tranberg-transperineal-mr-us-fusion-laser-induced-thermal-therapy-for-men-with-prostate-cancer-57962https://curecurrent.com/trials/safety-study-of-kpt-330-selinexor-in-patients-with-advanced-or-metastatic-solid-tumor-cancer-57963https://curecurrent.com/trials/mri-ultrasound-fusion-guided-prostate-cryotherapy-57964https://curecurrent.com/trials/ship-selinexor-in-hormone-insensitive-prostate-cancer-57965https://curecurrent.com/trials/protein-kinase-a-in-prostate-cancer-tissue-57966https://curecurrent.com/trials/myprostatescore-equivalency-with-and-without-dre-57967https://curecurrent.com/trials/mri-ultrasound-fusion-guided-laser-ablation-of-prostate-cancer-57968https://curecurrent.com/trials/sgb-in-men-treated-for-prostate-cancer-improve-hot-flashes-57969https://curecurrent.com/trials/recovery-from-dnmb-using-different-sugammadex-doses-in-elderly-patients-undergoing-robot-assisted-prostatectomy-57970https://curecurrent.com/trials/safety-of-prodencel-in-the-treatment-of-metastatic-castration-resistant-prostate-cancer-mcrpc-57971https://curecurrent.com/trials/applications-of-dual-energy-ct-in-patients-with-osseous-metastases-from-castrate-resistant-prostate-cancer-57972https://curecurrent.com/trials/can-dietary-phytoestrogens-slow-down-prostate-tumor-proliferation-57973https://curecurrent.com/trials/evaluation-of-clinical-and-pathological-characteristics-and-routine-treatment-of-patients-with-prostate-cancer-57974https://curecurrent.com/trials/use-of-an-experimental-drug-cc-115-with-enzalutamide-in-men-with-castration-resistant-prostate-cancer-57975https://curecurrent.com/trials/dose-escalation-study-of-preoperative-sbrt-for-high-risk-prostate-cancer-57976https://curecurrent.com/trials/health-status-quality-of-life-and-function-in-survivors-after-radical-treatment-for-prostate-cancer-part-iib-57977https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-stage-ii-prostate-cancer-57978https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-stage-ii-prostate-cancer-57979https://curecurrent.com/trials/hormone-therapy-with-or-without-docetaxel-and-estramustine-in-treating-patients-with-prostate-cancer-that-is-locally-adv-57980https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-of-participants-with-confirmed-prostate-cancer-using-64cu-sar-bispsma-propeller-57981https://curecurrent.com/trials/randomized-trial-of-psma-pet-scan-before-definitive-radiation-therapy-for-prostate-cancer-57982https://curecurrent.com/trials/pacct-partnering-around-cancer-clinical-trials-57983https://curecurrent.com/trials/177lu-psma-617-managed-access-program-for-mcrpc-patients-57984https://curecurrent.com/trials/prostate-cancer-prevention-clinic-for-men-with-risk-of-familial-prostate-cancer-57985https://curecurrent.com/trials/pilot-trial-evaluating-stereotactic-body-radiotherapy-with-integrated-boost-for-clinically-localized-prostate-cancer-rad-57986https://curecurrent.com/trials/preliminary-evaluation-of-uptake-in-bone-metastases-and-biodistribution-of-68ga-p15-041-57987https://curecurrent.com/trials/evaluation-of-hifu-in-treatment-of-localized-prostate-cancer-and-of-recurrence-after-radiotherapy-57988https://curecurrent.com/trials/impact-of-new-generation-hormono-therapy-on-cognitive-functions-in-elderly-patients-treated-for-a-metastatic-prostate-ca-57989https://curecurrent.com/trials/a-study-of-combined-mpmri-and-psma-pet-ct-for-highly-suspicious-patients-performing-radical-prostatectomy-without-biopsy-57990https://curecurrent.com/trials/exercise-for-improving-prostate-oxygenation-in-prostate-tumors-exipox-57991https://curecurrent.com/trials/longitudinal-evaluation-of-intestinal-haematological-and-urinary-toxicity-from-pelvic-irradiation-for-prostate-cancer-57992https://curecurrent.com/trials/validation-of-software-based-fusion-of-ultrasound-and-mri-images-of-the-prostate-57993https://curecurrent.com/trials/the-implantation-under-echography-of-fiducial-markers-in-the-intraprostatic-lesion-and-prostate-57994https://curecurrent.com/trials/a-study-of-pamiparib-combined-with-abiraterone-acetate-in-neoadjuvant-treatment-of-prostate-cancer-57995https://curecurrent.com/trials/oncological-and-functional-outcomes-after-radical-prostatectomy-for-prostate-cancer-comparing-open-with-robot-assisted-s-57996https://curecurrent.com/trials/diet-and-exercise-program-to-promote-weight-loss-and-improve-health-in-men-with-low-or-low-intermediate-risk-prostate-ca-57997https://curecurrent.com/trials/efficacy-and-safety-of-darolutamide-combined-with-adt-in-high-risk-very-high-risk-localized-prostate-cancer-57998https://curecurrent.com/trials/s9921-hormone-therapy-with-or-without-mitoxantrone-and-prednisone-in-patients-who-have-undergone-radical-prostatectomy-f-57999https://curecurrent.com/trials/pneumatic-compression-and-post-induction-hypotension-58000